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INTRODUCTION 
 
Siddha system is one of the most ancient medicine of Indian medicine. Siddha 
system of Medicine is a pioneering ancient medical system originated from Tamil Nadu. 
Siddhars ‘Who defined Death’, were of the concept that a Healthy Soul can be developed 
only through a Healthy Body. This ancient system of Medicine was developed by 18 
‘Siddhars’ who focused and attained “Ashtamahasiddhi”, the control over eight 
Supernatural Powers. 
This system of medicine uses a fascinating combination of Herbs, Minerals, 
Metals and Animal products to promote good health and longevity. Metalic preparations 
have been used to treat chronic diseases since time immemorial. Siddha medicine has 
immense faith in the miracles of mercurial drugs and in the prolongation of life through 
rejuvenating treatments and intense yogic practices The advantage and unique feature is 
the removal of the root causes of the disease and prefect remedy for body and mind. Role 
of these Herbo-mineral and Herbo-metallic preparations for treat diseases like diabetes, 
cancer, Hypertension, STD, AIDS, Leprosy, psoriasis, chronic ulcer,  etc. 
At present senario, the toxicity manifestation and related health problems 
produced in human and environment by heavy metals like Mercury, Lead, Arsenic etc. 
are considered to be a great threat to the society. Siddha proponents believe that the 
toxicity of these materials which are used in the Siddha formulations is reduced through 
purification processes such as Suddhi Muraigal. These methods not only deals with a 
purification of Heavy metals and Minerals, it also increasing the effectiveness of the raw 
drugs.  
Siddha system make clear words on the purification and preparation. Obviously  
Purification makes untainted drug. However formulated Siddha drugs need safety  
contour because of the preparation  procedures.   Many research workers have conducted 
a number of pharmacological and toxicological experiments and revealed that the toxicity 
of the crude drug is quite different from that of the finished Siddha formulations.  
Safety is the Major concern of treatment which demands evaluation whereas 
efficacy needs just a validation. Safety can also be defined to be the control of recognized 
hazards to achieve an acceptable level of risk. The problem all started with Paracelsus, 
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sometimes called the "father" of toxicology, who wrote: "The dose makes the poison." 
The original quote actually is: "All things are poison and nothing (is) without poison; 
only the dose makes that a thing is no poison." In other words, the amount of a substance 
a person is exposed to is as important as the nature of the substance. 
While there is no such thing as a safe chemical, it must be realized there is  
no chemical that cannot be used safely by limiting the dose or exposure.  
Poisons can be safely used and be of benefit to society when used appropriately. 
                                                                                 --Royal Society of Chemistry 
In the broadest sense, toxicology is the science of poisons and the harmful 
or noxious effects these substances have on living things. And is responsible for 
predicting the toxic or harmful nature of a substance by designing experiments that will 
supply the data necessary to assess the toxicity of materials. These data help clinician’s to 
make predictions about the hazardous nature of materials tested and their potential impact 
on the environment and on human populations. 
Siddha system give details of lot of formulations. “SIDDHAR KULIKAI” is 
imperative formulation to treat Parpala viranangal, Kiranthi rogangal, Yoniputru, 
Soolaigal, Kallippukiranthi, Lingaputru, Pouthirarogangal, Kanapilavai, Pakapilavai, 
Marsilanthi, Vipuruthi, 8types of gunmam, Maega ranangal.  
At the present prevalence of afore mentioned diseases were elevated. 
Astonishingly we have a choice of formulation “SIDDHAR KULIKAI” to treat diseases. 
The formulation was adapted from Veeramamunivar Vagadathiratu Part 1, 
page no 49. And there is no evidence about the safety profile of the formulation. 
The present investigation is aimed to carry out Acute and 28days Repeated Dose 
Oral toxicity study of “SIDDHAR KULIKAI”. The toxicity study of “SIDDHAR 
KULIKAI” is a step in the right direction of establishing  the safety. This study will 
provide scientific evidence for its safety profile, so its efficacy will be better ascertained 
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AIM AND OBJECTIVE 
Aim: 
 
To evaluate the Acute and 28 days Repeated oral toxicity study  of “Siddhar 
Kulikai” on   animal model (wistar albino rats). 
    
Objective: 
 
Ø To collecting literary evidences (Gunapadam, Chemical, Bio-chemical and 
toxicological aspects) in detail about the Siddhar Kulikai 
Ø Collection of raw drugs. 
Ø Method of Purification and preparation on the basis of siddha literary evidence. 
Ø Qualitative and Quantitative analysis of Siddhar Kulikai.  
Ø Acute toxicity study of Siddhar Kulikai when the drug was given in single oral 
dose administration of various dose levels by OECD GUIDELINE 423 
Ø 28 days Repeated dose toxicity study of Siddhar Kulikai when it was given in 
repeated oral dose by OECD GUIDELINE 407. 
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âÃõ 
(MERCUROUS CHLORIDE) 
 
§ÅÚ ¦ÀÂ÷¸û :  
   þÐÅ¡É Ãº¦ÁýÚõ ¿¢ÃïºÉ¦ÁýÚõ  
 þÉ¢Â¡¼õ ÒÅ¢Â¡¼ ¦ÁýÚõ §ÀÕ 
 «ÐÅ¡É Ãº¸üâÃ ¦ÁýÚõ §ÀÕ 
 «Ð«¾¢§Ä¡¸ ÁÕïº¡¸ ¦ÁýÚõ §ÀÕ 
 ÅÐÅ¡É ¦À¡ÕÁ¢¾¡¾ ¦ÁýÚõ §ÀÕ 
 ÅºÉ¢ò§¾¡õ þó¾ ¦Åñßü Å¡ï¨ºÀ¡¡£÷ 
 ÁÐÅ¡É «Ó÷¾õ ¯ñ¼Ð §À¡¨ÄÂ¡ 
 ÅºÉ¢ò§¾¡õ ¿¾£¾Ãº ¸üâÃò¾¢ý §À§Ã. 
i)Å¡¨¾Ãºõ,  
ii)¿¢ÃïºÉÁ¡,   
iii)þÅ¢Â¡¼õ,   
iv)ÒÄ¢Â¡¼õ,   
v)«¾¢§Ä¡¸ ÁÕïº¡¸õ,  
vi)¦À¡ÕÁ¢¿¡¾õ ±ýÀÉ.    
¦À¡ÐìÌ½õ: 
" þ¨¼Å¡¾ Ý¨Ä ¦Â¡¢Ý¨Ä ÌýÁó 
¦¾¡¨¼Å¡¨Æ Å¡¾Á¡ï §º¡½¢-Â¢¨¼Â¡§¾¡ 
¦Å¡ìÌÃº ¸÷ôâÃ ¦Á¡ý§È ÂÇ¦Å¡Î¿ø 
þìÌ¦ÅøÄò §¾Ø¿¡® 
¦À¡Õû : 
¿øÄ þÃº ¸÷ôâÃò¨¾ «Ç×¼ý ¸ÕõÒ ¦ÅøÄò¾¢ø 7 ¿¡û 
¦¸¡Îì¸, þÎô¨Àô ÀüÈ¢Â Ý¨Ä ¬í¸¡íÌ ±¡¢îº¨Äò ¾Õ¸¢ýÈ Ý¨Ä, 
Å¡¾ ÌýÁõ, ¦¾¡¨¼Å¡¨Æ, Å¡¾Ãò¾ §¿¡ö Ó¾Ä¢ÂÉ ¾£Õõ. 
 ÍÃõ, Áïºð ¸¡Á¡¨Ä, À¢ò¾ §¾¡¼õ, º£¾§À¾¢, ¿£÷ì§¸¡¨Å, 
Å¢Ã½ºó¿¢, ¬È¡¾ Å¢Ã½í¸û, §Á¸ Å¢Â¡¾¢, ¦º¡¢Â¡¨Á, Å¡ó¾¢, §À¾¢, ¸¢ÕÁ¢ 
§¿¡ö, ¸£øÅ¡¾õ, ¦º¡È¢, º¢ÃíÌ, ÁÄÀó¾õ Ó¾Ä¢Â¨Å¸ðÌõ, ¾¨ÄÅÄ¢ 
§À¡ýÈ Áü¨ÈÂ §¿¡ö¸ÙìÌõ ¯À§Â¡ì¢ì¸ôÀÎ¸¢ÈÐ. 
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Í¨Å      :    ¸¡÷ôÒ, ¯ôÒ. 
Å£¡¢Âõ    :   ¦ÅôÀõ. 
Å¢À¡¸õ    :   ¸¡÷ôÒ. 
¦ºö¨¸    :  ¯¼ø §¾üÈ¢, ¯Á¢ú¿£÷ ¦ÀÕì¸¢, ¸¢ÕÁ¢¿¡º¢É¢. 
º¢ÈôÒ Ì½õ :  À¢ò¾¿£¨Ã «¾¢¸ôÀÎòÐõ Ì½õ. 
    ¸Î¨ÁÂ¡É §¿¡ö¸¨Ç ºÁÉõ ¦ºöÔõ Ì½õ. 
    §À¾¢¨Â ¯ñ¼¡ìÌõ Ì½õ. 
âÃõ Íò¾¢ Ó¨È¸û:  
1)  âÃõ   -1 ÀÄõ 
ÓÍÓÍì¨¸ º¡Ú   -1/4 ÀÊ 
ÀÍõÀ¡ø             -1/4 ÀÊ 
âÃò¨¾ µðÊÄ¢ðÎ «Îô§ÀüÈ¢ ÓÍÓÍì¨¸ º¡ü¨È Å¢ðÎ 
ÍÕìÌ¦¸¡ÎòÐ «îº¡¦ÈøÄ¡õ ¦ºýÈÀ¢ý À¡Ä¡ø ÍÕì¸¢¼ §ÅñÎõ. 
À¡¦ÄøÄ¡õ ¦ºýÈÀ¢ý¸ðÊ¨Â ±ÎòÐ §ÁÖûÇ ¸Õì¨¸ ÍÃñÊ ¸ðÊ¨Â 
±ÎòÐ ¯À§Â¡¸¢òÐì ¦¸¡ûÇ§ÅñÎõ. 
    -«Û§À¡¸ ¨Åò¾¢Â ¿Å¿£¾õ Àì¸õ ±ñ-92 
 
2) 1ÀÄõ âÃò¾¢üÌ ¾¡öôÀ¡Ä¢É¡ø 3 Á½¢§¿Ãõ ÍÕìÌ ¦¸¡ÎòÐ 
À¢ý¦Åû¨ÇôâñÎ ¨¾Äò¾¢É¡ø 9 Á½¢§¿Ãõ ÍÕì¸¢ðÎ ±Îì¸×õ. 
-Ì½À¡¼õ Àì¸õ ±ñ-284. 
 
3)  ¸õÁ¡Ú ¦ÅüÈ¢¨Ä, Á¢ÇÌ ¬¸¢Â þÃñ¨¼Ôõ ¸¡ø ÀÄõ Å£¾õ 
¿¢ÚòÐ ±ÎòÐ º¢È¢Ð ¿£÷ Å¢ðÎ «¨ÃòÐ ¸ü¸ò¨¾ 1 ÀÊ ¿£¡¢ø ¸ÄóÐ 1 ÀÄõ 
âÃò¨¾ º£¨ÄÂ¢ø ÓÊóÐ ÐÄ¡Âó¾¢ÃÁ¡ö ¿£¡¢ø «Á¢ØõÀÊ ¦ºöÐ º¢Ú¾£Â¡ø 
±¡¢ì¸ §ÅñÎõ. ¿£÷ Óì¸¡üÀíÌ ÍñÊÂ À¢ÈÌ, âÃò¨¾ ±ÎòÐ, ¿£÷ Å¢ðÎ 
¸ØÅ¢ ¦ÅÂ¢Ä¢ø ¯Ä÷ò¾¢ ±Îì¸ Íò¾¢Â¡Ìõ. 
        -Ì½À¡¼õ Àì¸õ ±ñ-283. 
 
4)  âÃò¨¾ ºðÊÂ¢ø §À¡ðÎ ¦ÅüÈ¢¨Ä¨Â «¡¢óÐ §À¡ðÎ Á¢ÇÌ 
«òÐ¼ý §À¡ðÎ1/2 ÀÊò ¾ñ½£÷ Å¢ðÎ ¸¢Â¡ÆÁ¡ì¸¢ «¾¢ø âÃò¨¾ 
¸¢Æ¢¸ðÊ 3 ¿¡û °È ¨ÅòÐ ±Îì¸ Íò¾¢Â¡Ìõ.  
- Â¡ì§¸¡Ò ¨Åò¾¢Âõ 300 Àì¸õ ±ñ-5. 
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5) Àî¨º ¸ïº¡ þ¨Äîº¡Ú-1/2 ÀÊ 
¾¡öôÀ¡ø -2ÀÊ 
þÃñ¨¼Ôõ ¸ÄóÐ ¨ÅòÐ ¦¸¡ñÎ 10 ÀÄõ âÃò¨¾ µðÊø 
¨ÅòÐ «ÎôÀ¢ý Á£§¾üÈ¢ º¢Ú¾£Â¡¸ ±¡¢òÐ §ÁüÀÊ ¸Ä¨Å¨Â º¢Ú¸ º¢Ú¸ 
Å¢ðÎ ÍÕì¸¢¼ §ÅñÎõ. þì¸Ä¨Å ¿£¦ÃøÄ¡õ ¦ºýÈÀ¢ý âÃì¸ðÊ¨Â 
±ÎòÐ «¾ý Á£ÐûÇ ¸ÕìÌ Ó¾Ä¢Â¨Å¸¨Ç ¸ò¾¢Â¡ø ÍÈñÊ 
¿£ì¸¢¼×õ. 
º¡õÀ¢Ã¡½¢   -10 ÀÄõ 
¾£À ¸üâÃõ   -10 ÀÄõ 
þùÅ¢Ãñ¨¼Ôõ ¾É¢ò¾É¢§Â ¦À¡ÊòÐ À¢ÈÌ ´ýÈ¡ö ¸ÄóÐ 2 Àí¸¡ì¸¢ 1 
Àí¸¢¨É ¸£§Æ ÀÃôÀ¢ «¾ý Á£Ð Óý  Íò¾ôÀÎò¾¢É ¸ðÊ¨Â ¨ÅòÐ 
«¾ý§Áø ÁüÈ ´Õ Àí¸¢¨Éô §À¡ðÎ ¾¢¡¢Â¢É¡ø ¦¸¡Ùò¾¢¼×õ. 
à¦ÇøÄ¡õ ÀüÈ¢ ±¡¢ó¾À¢ý ¸ðÊ¨Â ±ÎòÐ §ÁÖûÇ ¸Õì¨¸ ¿£ì¸¢ 
¯À§Â¡¸¢òÐ ¦¸¡ûÇ×õ. 
- «Û§À¡¸ ¨Åò¾¢Â ¿Å¿£¾õ. Àì¸õ ±ñ-91. 
 
6)  âÃõ       - 1 ÀÄõ    
ÀÍõÀ¡ø     - 1/4 ÀÊ 
¸ðÊ¨Â µðÊÄ¢ðÎ §ÁüÀÊ À¡¨Ä º¢Ú¸ º¢Ú¸ Å¢ðÎ ÍÕì¸¢¼ 
§ÅñÎõ. À¡¦ÄøÄ¡õ ÍñÊÉÀ¢ýÒ ºðÊ¨Â ±ÎòÐ ¸ðÊÂ¢ÖûÇ ¸ÕìÌ 
Ó¾Ä¢Â¨Å¸¨Ç ÍÃñÊ ¿£ì¸¢ «¨ÃôÀÊ ¬Á½ìÌ ±ñ¦½¨Â ÌÅ¢Å¡É 
´ÕÀ¡ò¾¢Ãò¾¢ø Å¢ðÎ Óý º£¾ôÀÎò¾¢É ¸ðÊ¨Â ´Õ ¦ÁøÄ¢Â Ð½¢Â¢ø 
ÓÊóÐ ¸¢Æ¢¸ðÊ ±ñ¦½ö À¡ñ¼ò¾¢ø ¦¾¡í¸Å¢ðÎ À¡¨ÉÂ¢ý 
«ÊôÒÈõ À¼¡Áø ¦ºöÂ §ÅñÎõ. 2 «øÄÐ 3 º¡Áõ ¦ÁÐÅ¡¸ ±¡¢òÐ 
¬ÈÅ¢ðÎ ±ÎòÐ ±ñ¦½ö À¨º þøÄ¡Áø ¦ÁøÄ¢Â Ð½¢Â¢ø Ð¨¼òÐ 
±ÎòÐ ¦¸¡ûÇ §ÅñÎõ.  
-«Û§À¡¸ ¨Åò¾¢Â ¿Å¿£¾õ. Àì¸õ ±ñ-92. 
 
7) âÃõ  - 1ÀÄõ º¢Ú ÐñÎ¸Ç¡¸ ¦ºöÐ ¦ÁøÄ¢Â Ð½¢Â¢ø ¾Ç÷îº¢Â¡¸ 
ÓÊÂ×õ. ´Õ ÁñÀ¡ñ¼ò¾¢ø 2 ÀÊ ÀÍõÀ¡ø Å¢ðÎ «¾¢ø 5 ÀÄõ 
¸ïº¡¨Å àû ¦ºöÐ «øÄÐ ¾ñ½£÷Å¢ðÎ «¨ÃòÐ Óý ÓÊô¨À 
¸¢Æ¢¸ðÊ À¡ÖìÌû ¦¾¡í¸Å¢¼×õ. ÓÊôÀ¡ÉÐ À¡¨ÉÂ¢ÉÊÂ¢ø 
À¼¡ÁÄ¢Õì¸×õ §ÅñÎõ. À¡ø ÍñÊ1/4 ÀÊÂ¡Â¢ÕìÌõ §À¡Ð þÈì¸¢  
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¬ÈÅ¢¼ âÃò¨¾ Íò¾¢Â¡ì¸¢Å¢Îõ. Å¡öÀ¢ÊìÌõ Ì½ÓûÇ¾¡¨¸Â¡ø 
þ¨¾ §Áü¸ñ¼ÀÊ Íò¾¢ ¦ºöÅ¾¡ø «¾ý ¾£ÂÌ½õ ¿£íÌõ.    
            -«Û§À¡¸ ¨Åò¾¢Â ¿Å¿£¾õ. Àì¸õ ±ñ-91. 
 
âÃõ §ºÕõ À¢ÈÁÕóÐ¸û 
 
1) Å¡¨Ä ºïº£Å¢ Á¡ò¾¢¨Ã 
«Ç×   : ¯ÙóÐ À¢ÃÁ¡Éõ 
¾£Õõ §¿¡ö¸û  : Å¡¾ §Ã¡¸õ, Á¡ó¾õ, ÍÃõ 
- º¢§Ã¡Ãò¾¢É ¨Åò¾¢Â â„½õ. Àì¸õ ±ñ-48 
2)Àïº À¡„¡½ ¦ºóàÃõ.  
¾£Õõ §¿¡ö¸û  :ºýÉ¢ÍÃõ, Ý¨Ä Å¡¾õ, Ó¼ìÌ Å¡¾õ. 
-º¢§Ã¡Ãò¾¢É ¨Åò¾¢Â â„½õ. Àì¸õ ±ñ-60 
3)   Á¸¡ º¡òàÄ¡¾¢ì ÌÇ¢¨¸:            
«Ç×                :Íñ¨¼ì¸¡ö  
¾£Õõ §¿¡ö¸û :ÌýÁõ, Ó¼ìÌ Å¡¾õ, À£Ä¢¨¸, Ì¼ø Å¡Ô. 
-«¸ò¾¢Â÷ ¨Åò¾¢Â ÅøÄ¡¾¢-600. Àì¸õ ±ñ-35 
 
4)Ý¾ÅøÄ¡¾¢ ¯Õñ¨¼:             
«Ç×               :Á¢ÇÌ «Ç×          
¾£Õõ §¿¡ö¸û  :¸¢Ãó¾¢, Ìð¼õ, ÒüÚ, Å¢ôÒÕ¾¢, À¢Ç¨Å. 
-«¸ò¾¢Â÷ ¨Åò¾¢Â ÅøÄ¡¾¢-600. Àì¸õ ±ñ-20 
 
5) ÄŒÁ¢ ¿¡Ã¡Â½ Á¡ò¾¢¨Ã:               
«Ç×               :¯ÙóÐ «øÄÐ Á¢ÇÌ «Ç×         
«ÛÀ¡Éõ        :ÅºõÒ,µÁõ §º÷ó¾ ÝÃ½õ         
¾£Õõ §¿¡ö¸û   :¸£ø Å¡Ô 
-º¢¸¢îº¡ÃòÉ¾£Àõ. Àì¸õ ±ñ-152 
 
6) âÅÃºí¸¡ö ±ñ¦½ö:           
«Ç×                :1/4 ÀÄõ   
¾£Õõ §¿¡ö¸û   : ¦¸¡ÚìÌ, ¸¢Ãó¾¢, ¸Õ§Á¸õ. 
-º¢¸¢îº¡ÃòÉ¾£Àõ. Àì¸õ ±ñ-158 
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7) ºô¾Ãº º¢óàÃõ:          
«Ç×                :1/2 Ó¾ø 1 ÌýÈ¢           
ÛÀ¡Éõ       :§¾ý, ¦¿ö.                         
¾£Õõ §¿¡ö¸û    :Ý¨Ä, ÌýÁõ, À¡¡¢ºÅ¡ö×. 
- º¢¸¢îº¡ÃòÉ¾£Àõ. Àì¸õ ±ñ-159 
 
8) ¸üâÃ º¢ó¾¡Á½¢ Á¡ò¾¢¨Ã:         
«Ç×                :1/2 -1 Á¡ò¾¢¨Ã           
«ÛÀ¡Éõ         :º÷ì¸¨Ã, ¦¿ö.           
¾£Õõ §¿¡ö¸û    :Ó¼ìÌ Å¡Ô, Ý¨Ä §¿¡ö, ¸£øÅ¡Ô. 
- «Û§À¡¸ ¨Åò¾¢Â ¿Å¿£¾õ À¡¸õ-4. Àì¸õ ±ñ-60 
 
9) ÌÕÓ¨È À¾í¸õ:  
«Ç×                :1/2-1 «¡¢º¢ ±¨¼          
«ÛÀ¡Éõ         :À¨É ¦ÅøÄõ, ¦Åñ¦½ö, À¡§ÄÎ.         
¾£Õõ §¿¡ö¸û   :¸¢Ãó¾¢, ÌýÁõ, ºóÐ Å¡¾õ, ¿ÃõÒ Å¡¾õ. 
- «Û§À¡¸ ¨Åò¾¢Â ¿Å¿£¾õ À¡¸õ-7. Àì¸õ ±ñ-19 
10) ¸Õ§Á¸ §À¾¢: 
«Ç×        :1-1 1/2 ÅÃ¡¸ý 
«ÛÀ¡Éõ         :º÷ì¸¨Ã, Å¡¨ÆôÀÆõ. 
   ¾£Õõ §¿¡ö¸û   :¸Õô¨À Å¡Ô, Ó¼ìÌ Å¡¾õ. 
  - «Û§À¡¸ ¨Åò¾¢Â ¿Å¿£¾õ À¡¸õ-9. Àì¸õ ±ñ-27 
11) Ãº¸üâÃì¸ðÎ:                  
¾£Õõ §¿¡ö¸û   :ºýÉ¢, ÍÃõ, Å¡¾§¿¡ö¸û, ¿¡ÅÈðº¢.                        
    
-¬òÁÃðº¡Á¢÷¾¦ÁÛõ ¨Åò¾¢Â º¡Ãºí¸¢Ã¸õ-149 
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12) Ý¨Ä âÀ¾¢ Á¡ò¾¢¨Ã                 
«Ç×               :1-3 Á¡ò¾¢¨Ã          
«ÛÀ¡Éõ        :¦ÅøÄõ,          
¾£Õõ §¿¡ö¸û   :ÌÆ¢ôÒñ, º¢¨ÄôÒñ,Ó¼ìÌ Å¡Ô. 
 -«Û§À¡¸ ¨Åò¾¢Â ¿Å¿£¾õ À¡¸õ-9. Àì¸õ ±ñ82 
 
13) âÃ ÀüÀõ 
«Ç×: 1-2 «¡¢º¢, 3¿¡û þÕ§Å¨Ç 
¾£Õõ §¿¡ö¸û; ¦Åû¨Ç, ¦¸¡ÚìÌ,¨¸ ¸¡ø À¢ÊôÒ 
-À¾¡÷ò¾ Ì½Å¢Çì¸õ,47 
14)G+u vz;nza; 
  msT: miu(14 kp.ypl;)Kjy;xUmTd;];(28 kp.ypl;)  
  %d;W ehs; fhiy khj;jpuk; nfhLf;fTk;. 
  gj;jpak :;:cg;G> Gsp ePf;fTk;. 
  cgNahfk;: kyk;fopAk;> Foe;ijfspd; khe;jNeha; jPUk;. 
NkfNuhfq;fSk; Fd;kKk; ePq;Fk;. ,t;ntz;nzAld; tha;tplq;fj;J}s; 
Nrh;j;J cgNahfpf;f fpUkp ePq;Fk;. 
 
Gw kUe;Jfs; 
1.G+uf; fspk;G 
 cgNahfk ;: ,ijg; gwq;fpg; Gz;Zf;F Nky; NghlTk;. 
2.G+ug; nghb 
 cgNahfk; :nfhWf;Ff;F (Mz; Fwpapy; fpue;jpapdhy; cz;lhFk; 
Gz;) ,j;J}is NkNy J}tptuf; FzkilAk;. ,g;nghbia tl E}yhh; 
“gwq;fpf; Nfrhp” vd;W $Wth;. 
  
 
 
10 
 
âÃ ¿ïÍ 
Ø þÐ Å¢¨ÃÅ¡¸ ¿£¡¢ø ¸¨ÃÂ¡Ð. þÐ «¾¢¸ «ÇÅ¢ø ¯¼õÀ¢üÌû 
¦ºýÈ¡ø ¿ïÍ¾ý¨Á¨Â ¸¡ðÎõ. 
âÃ ¿ïÍ ÌÈ¢Ì½í¸û: 
 
Ø ÀøÄ£Ú¸Ùõ, ¿¡×õ, Å¡Ôõ, ¯ó¾¢Ôõ, ¾¡¨¼Â¢ý ¯ðÀì¸Óõ 
Òñ½¡Ìõ. 
Ø Å¡ö ¾¢Èì¸ ÓÊÂ¡Ð. 
Ø ¿¡Å¢ø ¿£÷ ÍÃìÌõ.«Ð ´Õ Å¨¸Â¡É ¿¡üÈòÐ¼ý þÕìÌõ.«¨¾ 
Å¢Øí¸ þÂÄ¡Ð. 
Ø Ó¸ò¾¢ø §Å÷ÌÕ, ÀÕ ¯ñ¼¡Ìõ, Á¡÷À¢ø ÀÕì¸ðÊ ¯ñ¼¡¸¢ô 
Òñ½¡Ìõ. 
Ø ¯ñ½¡ìÌ ÒñÀÎõ. 
Ø §À¾¢Â¢ø þÃò¾õ ÅÕõ, þÎôÀ¢ø ÅÄ¢ ¯ñ¼¡Ìõ, Å¢¨Ã Å£íÌõ. 
 
âÃ ¿ïÍ ÓÈ¢×  
Ø ÐÇº¢º¡Ú «øÄÐ º¢üÈ¡Á½ìÌ ¦¿ö «øÄÐ À¡¸ø þ¨Äîº¡Ú 
þ¨Å¸Ç¢ø ´ý¨È 3 «øÄÐ 5 ¿¡û «øÄÐ ¿ïÍ ¾£Õõ Å¨Ã 
¦¸¡Îì¸ §ÅñÎõ. 
Ø «×¡¢ §Å÷ôÀð¨¼¨Â ¦Åó¿£÷ Å¢ð¼¨ÃòÐ ´Õ §Å¨ÇìÌ 
Íñ¨¼ì¸¡ö «Ç× Å£¾õ ¸¡¨ÄÂ¢Öõ Á¡¨ÄÂ¢ÖÁ¡¸ ¿ïÍ ¾£Õõ 
Å¨Ãì ¦¸¡ÎòÐ ÅÃ  §ÅñÎõ. 
Ø ¿¢ÄôÀ¨É¸¢ÆíÌì ÌÊ¿£÷: 
¿¢ÄôÀ¨É¸¢ÆíÌ, ÅøÄ¡¨Ã, ¦À¡ýÉ¡í¸¡½¢ §Å÷, ¸ñÎÀ¡Ãí¸¢ 
¬¸¢Â ¿¡ýÌ ºÃìÌ¸¨ÇÔõ Å¨¸ìÌ 10 ¸¢Ã¡õ ±ÎòÐ º¢¨¾òÐ «¾¢ø 650 
Á¢.Ä¢ ¿£÷ Å¢ðÎ ±ðÎì¦¸¡ýÈ¡¸ ÌÊ¿£÷ ¦ºöÐ ¸¡¨ÄÂ¢Öõ Á¡¨ÄÂ¢ÖÁ¡¸ 2 
«øÄÐ 3 Å¡Ãõ ¦¸¡ÎòÐ ÅÃ âÃò¾¢ý Å£Ú¾½¢Ôõ. 
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¦¸¡Ê§ÅÄ¢ 
(Plumbago indica) 
Family Name :  Plumbaginaceae 
Hindi :  Kala-chitra 
Sans :  Chidraka 
Malai :  Nalla chitra mullam 
Kan :  Nila chitramua 
 
¦¸¡Ê§ÅÄ¢Â¢ý §ÅÚ ¦ÀÂ÷¸û: 
 
¸Äì¸Á¢øÄ¡ Å¾É¡¾¢ â¦¼ýÚõ §ÀÕ 
   ¸ÕÅ¡É Åì¸¢É¢§¸¡ Óîº¢ÃÅøÄ¢ 
  ÂÄì¸Á¢øÄ¡ ×ÀÅÃÇ¢¾ ¦ÁýÚõ §ÀÚ 
   µ¸¢¸¡Å¡Æ¡É Õò¾¢Åó¾Ãì¸ ¦¿ýÚõ §ÀÕ 
  ÁÄì¸Á¢øÄ¡ ÁÄ§¸¡Ê Å¡È¡¦ÉýÚõ §ÀÕ 
   ÅºÉ¢ò§¾¡ïî º¢ò¾Õì¸¡ö ±ð¦¼ðÎô  
  ÂÄì¸¦Áý§È ¿¼ì¨¸ ÂÈ¢Å¡¦ÉýÚõ §ÀÕ 
   «ÕÇ¢§É¡í ¦¸¡Ê §ÅÄ¢Â¾üÌô §ÀÕ 
§ÁÖõ 
                    «½¢ïº¢ø 
«Æø,  
º¢ò¾¢Ãõ,  
¾Æø,  
ÅýÉ¢,  
«¾¢ÀÐí¸¢,  
ÅÉõ,  
±¡¢,  
ÅÉÁ¡,  
¾¢Å¢À¢¿¡Áõ,  
          ¾¢ì¸¢, 
          ¾¢¨º,  
          ÅýÉ¢À¡¢Âõ, 
 ¦¸¡Ê§º¡¾¢,  
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 ¸¡ó¾õ,  
 À¸ôÀ¡¾¢,  
 À¡Å¢À¡Ç¢,  
 ¾Õ½¡ì¸¢É¢,  
 ÍÅ¡Ä¢É¢. 
 
ÀÂýÀÎõ ¯ÚôÒ : §Å÷ 
Í¨Å   : ¸¡÷ôÒ 
¾ý¨Á  : ¦ÅôÀõ 
À¢¡¢×   : ¸¡÷ôÒ 
¦ºö¨¸  : ¯ÃÁ¡ì¸¢, 
      Àº¢ò¾£òàñÊ. 
Å¨¸¸û: 
 3 Å¨¸¸û ¯ñÎ 
 ¸Õí¦¸¡Ê§ÅÄ¢ 
 ¦ºí¦¸¡Ê§ÅÄ¢ 
 ¦Åñ¦¸¡Ê§ÅÄ¢. 
¦À¡ÐìÌ½õ: 
    “¸ðÊÅ¢Ã ¿í¸¢Ãó¾¢ ¸¡ø¸û «¨ÃÂ¡ôÒì  
  ¸ðÊîÝ ¨ÄÅ£ì¸í ¸¡úãÄõ- ÓðÊÃò¾ì 
  ¸ðÎ¿£ §ÃüÈõ ¸Éò¾ ¦ÀÕÅÂ¢Úõ 
 «ðÎí ¦¸¡Ê§ÅÄ¢ Â¡õ.” 
 
¸ðÊ, Òñ, ¸Æ¨Ä, ÅÇ¢ §¿¡ö, «¨ÃÂ¡ôÒì¸ðÊ, Ìò¾ø, §º¡¨¸, 
ãÄ§Ã¡¸õ, ¯¾¢Ãì¸ðÊ, ¿£§ÃüÈõ, ¦ÀÕÅÂ¢Ú §À¡õ. 
 
“¸ðÊ§Â Ý¨Äì¸ðÊ ¸Õ¾¢Î ÌÈ¢ôÒñ ¸¢¡¢ó¾¢ 
 ´ðÎ§Á ¸Ã½ò§¾¡Î ÓÚÁ¨Ã Â¡ôÒ ÁýÈ¢ 
 Å¢ðÊ¼¡ ¦¿È¢îÍ ÃõÀ¢ý Å¢ÂýÅ¢¼  ¿îÍ Ãó¾ý 
 ¦À¡ð¦¼Éô ÀÈóÐ §À¡Ìõ Ò¸ú¦¸¡Ê §ÅÄ¢ ¸ñ¼¡ø”. 
 
Ý¨Äì¸ðÎ, ÌÈ¢ôÒñ, ¸¢Ãó¾¢, §Á¸ôÒñ, ¦¿È¢ÍÃõ, ¿îÍÍÃõ Ó¾Ä¢Â¨Å 
¾£Õõ. 
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¦Åñ¦¸¡Ê§ÅÄ¢ 
(Plumbago Zeylanica) 
 
§ÅÚ ¦ÀÂ÷ : ¦Åñº¢ò¾¢ÃãÄõ,¦Åñ¦¸¡ÊãÄõ 
Eng  : Ceylon lead-wory 
Sans  : Chitraka-vrikshaha 
ÅÇÃ¢ÂøÒ :þó¾¢Â¡Å¢ø ±íÌõ ÅÇÕõ 
Í¨Å  : ¸¡÷ôÒ, Å¢ÚÅ¢ÚôÒ 
¾ý¨Á : ¦ÅôÀõ 
À¢¡¢×  : ¸¡÷ôÒ 
nra;if : Kiwntg;gfw;wp    
  tpah;itAz;lhf;fp   
,jd; Nthpd; gl;ilapdpd;Wk; nra;ag;gLk; FbePh; Kjypaitfl;Fk; Nkw;gb 
nra;iffSz;L.  
Fzk; : fUq;nfhbNtypf;Fs;s FzNk ,jw;FKz;L. 
msT : fhy; Kjy; miu tuhfndil msTf;F kpQ;rpdhy; tplkpf;Fk;. 
 
nfhbNtyp Nth; 
nra;if : cw;rhffhhp>  
KiwtpahjpNuhjp>  
RNtjfhhp>  
UJth;j;jdfhyp>   
 
cgNahfpf;Fk; Kiw :  
Ø ,jd; Nth;g;gl;ilia miuj;J Ntisf;F ¼ my;yJ ½ Rz;ilf;fha; 
gpukhzk; gRtpd;ghypyhtJ my;yJ nts;shl;Lg;ghypyhtJ fyf;fp 10 
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my;yJ 15 ehs; nfhLj;Jtug; gioaRuk;> GiuNahLk; miuahg;Gf; fl;b> 
R+iyf;fl;L> R+iyg;gpbg;G> ntbR+iy> Njfj;jpy; fuLKulhff;fl;LQ;R+iy> 
cs; %yk;> fpue;jp> fUg;gthA Kjypa gy gpzpfs; jPUk;. 
 
Ø ];jphPfSf;F tPl;L tpyf;fk; rhpahff; fhzhj rkak; ,jd; Nth;g;gl;ilia 
miuj;Jr; Rkhh; ½ Rz;ilf;fha;g;gpukhz nkLj;J xU NfhopKl;ilapYs;s 
ntz; fUtpy; fyf;fpf; nfhLf;fTk;. ,g;gbj; jpdk; fhiy khiy 3 ehs; 
nfhLf;f khj tpyf;fk; rhpahff;fhZk;. R+jfthAitAk; fz;bf;Fk;. 
 
 
Ø xU gb gRtpd; ghypy; xU gyk; rpj;jpu %yj;jpd; gr;irg; gl;iliaj; 
jl;bg;Nghl;Lr; rptf;f fha;r;rp tbfl;b gpiuNkhh; Fj;jp kWehl; file;J 
ntz;nza; vLj;J md;dj;jpypl;Lr; rhg;gplTk;. mg;NghJz;lhFk; NkhiuAk; 
md;dj;Jld; Nrh;j;Jf;nfhs;tJld; kpFjpg;gl;bUe;jhy;> rpWf rpWff; 
Fbj;JtplTk;. ,g;gb 3 ehs; rhg;gpl %yKis mw;WtpLk;. ,J mjpf c\;z 
tPhpa Ks;sjhifahy; rhPuj;jpd; td;ik nkd;ikf; Nfw;wthW msit 
rhpg;gLj;jpf;nfhs;sNtz;Lk;. 
 
Ø nrq;nfhbNtypg; gr;irNth;g;gl;ilia ePh; tpl;liuj;J> gr;rhprpkhT Nrh;j;J 
ed;wha; fye;J> rPiyapw;wltp> miu kzp Neuk; nfhg;Gspf;fr; nra;aNtz;ba 
,lj;jpy; Nghl;nlLf;f> 12 Kjy; 18 kzp Neuj;Jf;Fs; ehd;F GwKk; gutpa 
nfhg;GsKz;lhFk;. mf;nfhg;Gsq;fspYs;s ePiug;Nghf;fpj; jsph; thio 
apiyia itj;Jf;fl;bg; Gz;iz Mw;WtJ tof;fk.; 
 
Ø fUg;igia mfykhf;FQ; nra;ifia cz;lhf;f> ,jd; Ntiu mt;tplk; 
nrYj;jf;fUit ntspg;gLj;Jk;. Nth;g;gl;ilia miuj;J> xU tuhfndil 
msthf cl;nfhs;tJk; cz;L. 
 
Ø cyh;e;j Ntiu miuj;J Nkfg;gil> Fl;lk; ,itfSf;F Nkw;G+r;rhf 
toq;fyhk;. 
  
Ø nfhbNtyp Ntiug; ghf;fsT miuj;J> gRtpd; ghypy; (fwe;j Mtp khWKd;) 
fiuj;Jf;Fbf;f> gh\hzj;jpd; tPW jzpAk;. 
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Ø gr;irNtiu md;d tbfQ;rpePh; tpl;liuj;J> Jzpapy; jltpg; Gz;zhf;f 
Ntz;ba ,lq;fspy; Nghl ½ kzp Neuj;jpw;Fs; vhpr;ry; kpFk;. vhpr;ry; kpFe;j 
Neuk; Jzpia vLj;J tplf; nfhg;gspj;Jg; Gz;zhFk;. Jh;ePh; ntspahFk;> 
gpd;dhy; mg;gl;lkhd Njq;fha; vz;nziaj; jltptu MWk;. 
 
Ø ,ij miuj;Jr; rPiyapy; jltpj;jphpNghy; jpul;bf; fUg;igia Kl;Lk;gbahf 
itj;Jg; Gz;zhf;fpf; fUit mopg;gJz;L. 
 
 
nfhbNtyp §ºÕõ À¢ÈÁÕóÐ¸û 
1.nfhbNtyp vz;nza; 
,j;ijyj;ij ,uz;L my;yJ %d;W ehs; jiyapy; itj;Jj; jiy KOfptu> 
ePh;g;gPdrk;> Jk;ky;> jPuhj;jiytyp ,itfs; jPUk;. thj Neha;fSk; NghFk;.  
2.rpj;jpu %yf;Fspif 
 kpsfsT cUz;il nra;J> gj;J ehs; rhg;gpl;Lg; gj;jpak; ,Ue;Jtu> 
tpuzk;> ,uzf;fpue;jp> Nahdpg;Gw;W> R+iy> fs;spg;G+f;fpue;jp> ypq;fg;Gw;W> 
gTj;jpuk;> fd;dg;gpsit> gf;fg;gpsit> khh;rpye;jp> tpg;GUjp> Nkfuzk;> 
vl;Ltpjf;Fd;kk; ,itfs; NghFk;.  
3.nfhbNtypf; FbePh; 
 nfhbNtyp Nth;g;gl;il> gwq;fpg;gl;il> gpug;gq;fpoq;F> kpsF ,it 
tiff;F %d;W tuhfndil vLj;J ,bj;J> 5>600kp.yp ePhpw;fye;J 700 kp.yp 
FWf;fp> ehs; xd;Wf;F %d;Wjuk; 130kp.yp tPjk; rhg;gpl;Ltu> 
thAtpdhYz;lhFk; clk;Gf;Fj;jy; NghFk;.  
4.nfhbNtypg;nghb. 
 Ntis xd;Wf;F %d;W tpuy; msT ehw;gJ ehl;fs; nfhs;s fpufzp> 
cjuthA> %ythA> thjthA> gl;rthjk; Kjypad jPUk;. 
5.rpj;jpu%y nea; 
 Mtpd; nea; gyk; 8> Rj;jkhd ey;nyz;nza; gyk; 8 ,itapuz;ilAk; 
xU gofpd kl;ghz;lj;jpypl;L mjdpy; ,uz;Lgyk; rpj;jpu%yk; 
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Nth;g;gl;iliaAk; ,uz;L gyk; nts;is ntq;fhaj;ijAk; miuj;Jg;Nghl;Lf; 
fyf;fp mLg;gpNyw;wp tz;ly; nkOFgjk; tuf;fha;r;rp tbj;Jnfhs;f. jpdk; 
fhiy khiy ½ mTd;]; tPjk; 10 my;yJ 12 ehs; nfhLf;f cl;nfhjpg;G> 
nts;is> R+jfge;jk;> iffhy; gpbg;G Kjypaitfs; ePq;Fk;. gj;jpakpy;iy. 
6.¦¸¡Ê§ÅÄ¢ §Ä¸¢Âõ: 
«Ç×  : ¦¸¡ð¨¼À¡ìÌ, 2 §Å¨Ç, 15 ¾¢Éõ. 
 ¾£Õõ Å¢Â¡¾¢: Ý¾¸ Å¡ö×. 
     -À¢ÃÁÓÉ¢ ¨Åò¾¢Â º¡ì¸¢Ãõ À¡¸õ 1 
7.º¸Ä ÍÃ¸¢Â¡Æõ: 
 «Ç×  : 1/4 ÀÊ, 3 ¾¢Éõ, 6 §Å¨Ç 
 ¾£Õõ Å¢Â¡¾¢: º¸Ä ÍÃõ 
     -Ã½ ¨Åò¾¢Â º¢ó¾¡Á½¢-567 
 
8.Ã½ ±ñ¦½ö:  
 «Ç×  : ¯îº¢ì¸ÃñÊ, ¸¡¨Ä kl;Lk, ;5 ¾¢Éõ 
 ¾£Õõ Å¢Â¡¾¢: º¸Ä Å¢Ã½õ 
 Àò¾¢Âõ  : ¯ôÒ ÅÚòÐî §º÷ì¸×õ.  
   -Ã½ ¨Åò¾¢Â º¢ó¾¡Á½¢ 
Gw kUe;Jfs; 
  
1.nfhbNtypg;gw;W 
 nfhbNtypNtiu ey;nyz;nza;> tpl;liuj;Jg; gw;WNghl> fUiz%yk;> 
miuahg;G> fz;lkhiy ,it fiuAk;.  
2.nfhbNtypj; ijyk; 
 jiy KOfptu Mde;jthA> nrhwp> rpuq;F> jpdT> Fl;lk;> miuahg;G 
fpue;jp> R+iy> Gz;Giufs;> gpsit> tPf;fk; ,itfs; jPUk;.  
,j;ijyj;ij> fPy;thjk;> gl;rthjk; ,itfl;Fg; G+rf; FzkhFk;. 
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nfhbNtyp  eQ;R 
,jd; Nth;g;gFjpapy; kl;Lk; Plumbagin 2 Methyl - 5 Hydrodxyl 
1Naphithaquinone’4 ,J kQ;rs; epwj;jpy; Crpfs; Nghd;W ,Uf;Fk;. ePhpy; 
fiuahJ. nte;ePhpy; fiuAk;. ,jd; Ntiu ntspg; G+r;rhfg; gad;gLj;jpdhy; 
cWj;jiy cz;lhf;Fk;. Fiwe;j mstpy; Ez;kq; nfhy;ypahfr; nray;gLk;. tha; 
%ykhf cl;nfhz;lhy; ,jaj; jirfspy; nray;gl;L gy RUf;fq;fis 
Vw;gLj;Jk;. kpFjpahd msT cl;nfhs;Sk;NghJ EiuaPuypy; nray;gl;L 
caph;g;Gj; jilia Vw;gLj;Jk;. mJ njhlh;ghf caphpog;G Vw;gLk;. 
eQ;Rg; ghfk;   : Nth;g;gFjp 
cah;e;j msT : 5 fpuhk; 
caphpog;Gf; fhyk;  : ÌÈ¢ôÀ¢¼À¼Å¢ø¨Ä 
FwpFzq;fs; :  
Ø ,jid ntspahl;rpahfg; gad;gLj;Jk;NghJ cWj;jiy cz;lhf;fpr; 
rpWrpW nfhg;Gsq;fis Vw;gLj;Jk;.  
Ø msTf;F mjpfkhfg; gad;gLj;Jk;NghJ cwf;fj;ij cz;lhf;Fk;.  
Ø ,iug;ig> Flw; gFjpfspy; cWj;jiy cz;lhf;fp ePh;kyg; Nghf;fpid 
Vw;gLj;Jk;. njhlh;epiyahf the;jp Ngjp Vw;gLj;Jk;. NkYk; tapw;W typ 
kpFjpahFk;.  
rpj;j kUj;Jtk; 
ehl;lha; nfhbNtyp ey;Nyhh; jdf;FeP 
$l;lha; eWnea;iaf; $rhky; - thl;lkpyh 
khl kiuj;jjid khNjjpy nea;apy;  
Nghl;Ltil ahf;fpg; Grp 
Ø gR nea;iaf; Fbf;f Ntz;Lk;. 
Ø ey;nyz;nzapy; cSe;Jtil Rl;L cz;zyhk;. 
Ø Nga;g;gPh;f;F> Nfhiuf;fpoq;F Mfpa ,uz;ilAk; Nrh;j;Jf; FbePhpl;Lf; 
nfhLj;jhYk; eQ;R ePq;Fk;. 
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µÁõ 
(CARUM CAPTICUM) 
 
Family       : Umbelliferae 
NtW ngah   : mrNkhjk;>  
   jPg;gpak;  
    «ºÁ¾¡¸õ,  
    §¸¡ì¸¢÷¦¸ó¾õ,  
    ÌýÁò¨¾ô§À¡ì¸¢,  
    Ðº§Á¡¾ïÍÅÃ¢,  
    «º§Á¡¸ þôÀ¢Â¸õ,  
    Á¸¡òÀÉ¢,  
    ÒºÅý,  
    ¦º¼ò¾¢ý ¸¢ÕÁ¢ §À¡ì¸¢,  
    Å¡¾¸À ºÁÉ¢. 
 Rit       : fhu;g;G> 
jd;ik       : ntg;gk; 
gpupT        : fhu;g;G 
nra;if      : grpj;jP Jhz;b>  
    ,rptfw;wp>  
    mfl;Ltha;tfw;wp 
    mOfyw;wp>  
    ntg;gKz;lhf;fp>  
    cukhf;fp  
    ckpo;ePu;ngUf;fp 
gad;gLk; ghfk; :  tpijfs; 
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Fzk;       : 
   “rPjRuq;fk; fhrQ; nrhpahke; jk;nghUky;  
  Ngjpapiur; ry;fUg;G Nguhkk; - XjpUky;  
   gy;nyhLgy; %yk; gFkpitNeh nad;nrANkh?  
   nrhy;nyhLNghk; Xknkdr; nrhy;” (m.F) 
ÍÃõ, þÕÁø, ¦º¡¢Â¡Á¡ó¾õ, ¦À¡ÕÁø, ¸Æ¢îºø, °Æ¢, Ì¼Ä¢¨Ãîºø, 
þ¨ÃôÒ, Àø §¿¡ö, À¸ó¾¢Ãõ þ¨Å¸s; §À¡õ. 
-Fzghlk; -%ypif tFg;G gf;f vz;. 173> - 7k; gjpg;G 
Rj;jp :   
Ø Rz;zhk;G njspT ePhpy; 1 rhkk; Cwitj;J vLf;fTk;. 
 
Ø Xkk;> Rf;F> rpj;jpu%y Nth;g;gl;il> ,k;%d;Wk; nghbj;J xd;W fye;J> 
fye;j vilf;F> Neh;> fLf;fha;g;nghb $l;b Ntisf;F %tpuy; msT 
Nkhhpy; nfhLf;f> ke;jk; ePq;Fk; 
 
Ø Xkj;ijr; ryk;tpl;liuj;Jf; fspNghy; fpswpj; jhsf; $ba R+l;by; 
NehAs;s ghfj;jpy; itj;Jf;fl;l mt;tplj;jpYs;s NehAk; tPf;fKk; NghFk; 
 
Ø Xkj;ij ,bj;Jj; J}s; nra;J xU rd;dkhd rpiyapy; Kbr;Rf;fl;b mij 
mbf;fb ehrpapy; itj;J Nkhe;Jnfhz;bUf;f [yNjh\k;> rd;dp 
Kjypaitfs; NghFk;. 
 
Xkk; §ºÕõ À¢È ÁÕóÐ¸û: 
1.Xkj;jPePh; 
 msT : 30 kp.yp Kjy; 60kp.yp 
jPUk; Neha;: Cop> tapw;Wg;nghUky;> tapw;Wtyp> nrhpahf; fopr;ry;> ke;jk; 
,itfisg; Nghf;Fk;.. mfl;Ltha;tfw;wp nra;if ,jw;Fz;L.  
2.Xkj; ijyk; 
jPephpd;kPJ kpje;jJ gbAk; vz;nza; Xkj;ijynkdg;gLk;. 
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 msT : 1 Kjy; 3 Jsp tiu  
 jPUk; Neha;: Cop> tapw;Wg;nghUky;> tapw;Wtyp> nrhpahf; fopr;ry;> ke;jk; 
,itfisg; Nghf;Fk;.. mfl;Ltha;tfw;wp  nra;if ,jw;Fz;L. 
3.µÁõ- ¬ì¸¢Ã¡½õ: 
 «Ç×: À½¦Å¨¼ 
 ¾£Õõ Å¢Â¡¾¢: ºÇ¢, ¾¨Ä À¡Ãõ 
-§¾¨ÃÂ÷ ¨Åò¾¢Âõ 1000 
4.º¢Å¨¾ §Å÷ ÝÃ½õ: 
 «Ç×; 2 Å¢Ãø, ´Õ §Å¨Ç, 20 ¾¢Éõ 
 ¾£Õõ Å¢Â¡¾¢: ÁÄì¸ðÎ Å¢ÄÌõ. Àº¢ ¯ñ¼¡Ìõ. 
 Àò¾¢Âõ: ÒÇ¢ Å¢Çì¸×õ. 
-À¢ÃÁÓÉ¢ ¨Åò¾¢Â º¡ì¸¢Ãõ À¡¸õ 1 
 
5.§¿÷Å¡Çì ÌÇ¢¨¸:  
  «Ç×    : ¸¼¨Ä 
  «ÛÀ¡Éõ        : §Á¡Ã¢ø 
  ¾£Õõ §¿¡ö¸û: ÌýÁõ 
-«¸ò¾¢Â÷ ¨Åò¾¢Â º¢ó¾¡Á½¢, 125 
6.º¾¡§ÅÃ¢ ¦¿ö: 
«Ç× : 16 Á¢.¸¢ 
 ¾£Õõ §¿¡ö¸û: ±ÖõÒÕì¸¢, º¨¾Â¨¼ôÒ, ¿£÷¸ÎôÒ, ¦Åð¨¼,  
       À¢Ã§Á¸õ 
 -«¸ò¾¢Â÷ ¨Åò¾¢Â º¢ó¾¡Á½¢, 57 
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À¨É 
(BORASSUS FLABELLIFER) 
 
Family Name : Palmaceae 
§ÅÚ ¦ÀÂ÷ : ¾¡Äõ,  
           ¸ÕõÒÃõ,  
           ²¼¸õ,  
                    ¸¡Áõ,   
           ¾Õùô þÃ¡¸ý,  
           ¾¡Ç¢. 
 
ÅÇ¡¢ÂøÒ: 
þó¾¢Â¡ ÓØÅÐõ ¾¡É¡¸ µí¸¢ ÅÇÕõ ÁÃõ. þ¨Ä¸û Áð¨¼, â, 
§Å÷ þ¨Å¸û ÁÕóÐ¸ÙìÌ ÀÂýÀÎ¸¢ýÈÉ. 
 
ÀÂýÀÎõ ¯ÚôÒ :  À¨ÉÅøÄõ, ÌÕòÐ, µ¨Ä, ÑíÌ, ÀÆõ,Áð¨¼¸û 
þ¨Ä, Áð¨¼, §Å÷: 
 Í¨Å : ÐÅ÷ôÒ 
 ¾ý¨Á : ¾ðÀõ 
 À¢Ã¢× : þÉ¢ôÒ 
¸û: 
 Í¨Å : þÉ¢ôÒ 
 ¾ý¨Á : ¾ðÀõ 
 À¢Ã¢× : þÉ¢ôÒ 
¦ºö¨¸ : 
þ¨Ä, Áð¨¼ : 
  ÐÅ÷ôÀ¢, 
  ¬ñ¨Á ¦ÀÕì¸¢, 
  
 
 
22 
 
ÑíÌ : 
º¢Ú¿£÷ ¦ÀÕì¸¢ 
¯ûÇÆÄ¡üÈ¢ 
¯¼ÖÃÁ¡ì¸¢ 
ÁÐ : 
  º¢Ú¿£÷¦ÀÕì¸¢ 
  ÌÇ¢÷îº¢Ôñ¼¡ì¸¢ 
¸û : 
 ¦ÅôÀÓñ¼¡ì¸¢ 
¾¡ÀÁ¸üÈ¢ 
â¨Åô À¾ôÀÎò¾¢, «¾ý Ó¨É¨Âî º£Å¢ Å¡öÅÆ¢Â¡ö ÅÊÔõ ¿£¨Ãì 
ÌÎ¨Å¸Ç¢ø ¾íÌõÀÊ¦ºöÐ ±Îì¸¢ýÈÉ÷. þ¾üÌì ¸û ±ýÚ ¦ÀÂ÷. 
«ìÌÎ¨ÅÂ¢ø ¦¸¡ïºõ Íñ½¡õÒ ¾¼Å¢É¡ø ÒÇ¢ì¸¡Ð. þ¾üÌô À¾É£÷ 
«øÄÐ ÀÉïº¡Ú ±ýÚ ¦ÀÂ÷. 
ÒÇ¢ì¸¡¾ ¸û «øÄÐ À¾É£¨Ãì ¸¡¨ÄÂ¢ø 40 ¿¡ð¸û º¡ôÀ¢ðÎ ÅÃ 
§Á¸ §¿¡ö ¾½¢Ôõ.  
  
   "þ§ÃÅ¾¢ÅÃýÁ¡¨ÄÁó¾¢Ãõ 
  þÌò¾¢Î§Á¸ÅÉíÌô¨À¦ÂøÄ¡õ". 
        -§¾Ãý ¸¡ôÀ¢Âõ 
À¾É£Ã¢Ä¢ÕóÐ ¦ÅøÄõ, ¸ü¸ñÎ, º÷ì¸¨Ã Ó¾Ä¢Â¨Å ¦ºöÂÄ¡õ. 
ÀÉïº¡üÈ¢É¢ýÚ ÅÊò¾ ¦ÅøÄõ 
Palmyra Jaggery extracted from the juice. 
      -258, vol-V T.V.Sambasivam pillai 
À¨É¦ÅøÄõ: 
 “ÅðÎÀÉ ¦ÅøÄò¾¡ø Á¡÷¦À¡¢îºø ÌýÁÁÚõ 
 ÓðÎ ¾¢¡¢§¾¡„õ ÓýÉ¢ü¸¡- ¸ðÎôÀ¼¡ 
 Å¡ó¾¢ Õº¢Â¢ý¨Á Å¡Ç¡ ÔüÈ¢ÊÛõ 
 º¡ó¾¢ ¦ÀÕÌ¦Áý§È º¡üÚ”. 
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Ì½õ: 
À¨É¦ÅøÄò¾¡ø ÍÃºó¿¢À¡¾õ, ¾¢¡¢§¾¡¼õ, «§Ã¡º¸õ, ÌýÁõ, Á¡÷Ò 
±¡¢îºø þ¨Å¸û ¿£íÌõ. 
 
¯À§Â¡¸¢ÌìÌõ Ó¨È: 
À¨É ¦ÅøÄò¨¾ì ¸¨ÃòÐ ÅÊ¸ðÊô À¡Ì ±ÎòÐô Àî¨º «¡¢º¢Á¡× 
ÜðÊ «¾¢ÃºÁ¡¸ ÍðÎ ¯ñÀÐñÎ. ¸¡À¢, ¾ñ½£÷ þ¨Å¸Ç¢ø 
º¡¾¡Ã½Á¡¸ º÷ì¸¨ÃìÌô À¾¢Ä¡¸ þó¾ô À¨É  ¦ÅøÄò¨¾ô §À¡ðÎî 
º¡ôÀ¢ÎÅÐñÎ. 
þ¾É¡ø §¾¸ò¾¢ý ¦ÅôÀõ «¼íÌõ, À¢ò¾õ ¾½¢Ôõ, §¾¸ 
¬§Ã¡ì¸¢Âõ ¯ñ¼¡Ìõ. 
À¨É¦ÅøÄì ÌÊ¿£÷: 
 "ÅøÄ ÍÃõ¦ÀÕ Á¡ó¾õ§À¡ó §¾¡„õ§À¡ï 
 ¦º¡øÄ¦ÅÌ §Á¸õ§À¡ï §º¡¨¸§À¡õ- ¿øÄ¡ö§¸û 
 ¾¡Ä¦ÅøÄï ÍìÌ¼§É ºü§È ¿¢ÄìÌÁ¢í 
 ¸¡Ä§Á ¸¡öîº¢Ô½ì ¸¡ø." 
À¨É ¦ÅøÄìÌÊ¿£¨Ãì ¸¡¨ÄÂ¢ø ÌÊì¸ ÍÃõ, Á¡ó¾õ,§¾¡„õ,§Á¸õ, 
§º¡¨¸ Ó¾Ä¢ÂÉ ¾£Õõ. 
 
«ÛÀ¡ÉÁ¡¸ À¨É¦ÅøÄõ: 
 º¡ôÀ¢¼ §ÅñÊÂ ÁÕó¨¾ ¦À¡¾¢ò§¾¡ §ÅÚ Å¢¾Á¡¸ 
¯Õº¢Ôñ¼¡ìÌõÀÊì ¸Äó§¾¡ ±Ç¢¾¢ø ¯ð¦ºÖò¾ §ÅñÊ 
¯ð¦¸¡ûÙõ §¿¡ö¸ÙìÌ «ÛÀ¡ÉÁ¡¸ À¨É¦ÅøÄõ 
ÀÂýÀÎò¾ôÀÎ¸¢ÈÐ. 
528, vol-V T.V.Sambasivam pillai 
À¨É¦ÅøÄõ §ºÕõ À¢È ÁÕóÐ: 
1.§Á¸ ÍÃ ¸¢Â¡Æõ:  
 «Ç×: 1/4 ÀÊ 
 ¾£Õõ Å¢Â¡¾¢:¿¡ðÀð¼ §Á¸ÍÃõ ¾£Õõ. 
- «Û§À¡¸ Ã½ ¨Åò¾¢Â º¢ó¾¡Á½¢ 
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§¸¡§Ã¡ºÉõ 
 
§ÅÚ ¦ÀÂ÷ :  §Ã¡ºÉõ, §¸¡Áó¾¢Ãõ, ÅîºÄÁ½¢, ƒ¡¾¢ 
«¾£¾¦ÁýÈ Å¼Õ¦º¡Ä Á¡ÕÅ¡í¸¢ ¦ÂýÚõ 
«Ç¡Éì ¸ÄïºÅ¡¡¢ ¦ÂýÚõ §ÀÕ 
Á¾£¾¦ÁýÚ ÅýÉÁ¨¾ ¦ÂýÚõ §ÀÕ 
Á¸ò¾¡Éò ¾¢ÕÅ¦ÁýÚ Á¾üÌô §ÀÕ 
¦À¡¾£¾¦ÁýÈ Òí¸¡ðÊ ¦ÂýÚõ §ÀÕ 
Ò¸Æ¡É ¿¡Å¸ñ½¡Ê ¦ÂýÚõ §ÀÕ 
¦º¸£¾¦ÁýÈ §º§Ã¡ó¾¢ ¦ÂýÚõ §ÀÕ 
¦ºôÀ¢§É¡í §¸¡§Ã¡º¨Éì¸¢ð ¦ÂðÎõ §À§Ã. 
 
 ¦¸×¾Á¢,  
 Á¢í¸Ç À¢ÃÁ¢,  
 ¦¸×Ã¢,  
 ¦¸×Ã¢ À¢ñ¼õ,  
 Á¡§Áò¾¢Â¡,  
 À×ò¾¢Ã¢,  
 À¢ò¾À¡ºÉ¢,  
 
Í¨Å  : ¨¸ôÒ 
Å£¡¢Âõ : ¦ÅôÀõ 
À¢¡¢×  : ¸¡÷ôÒ, 
¦ºö¨¸ : ÁÄÁ¢Çì¸¢,  
     þº¢Å¸üÈ¢,  
     ÌÇ¢÷îº¢Ôñ¼¡ì¸¢,  
     À¢ò¾ºÁÉ¢,  
     §¸¡¨ÆÂ¸üÈ¢. 
Ø ÀÍÅ¢ý À¢ò¨¾ì ÌÈ¢ìÌõ ¦À¡ØÐ §¸¡ÃºÉõ ±ýÚõ, ¬ðÊý 
À¢ò¨¾ì ÌÈ¢ìÌõ ¦À¡ØÐ ¨Á§Ã¡ºÉõ ±ýÚõ ÅÆí¸ôÀÎ¸¢ÃÐ. 
Ø ¦ÀÕõÀ¡Öõ ÁÕóÐ¸Ç¢ø ÀÍÅ¢ý §Ã¡ºÉ§Á ¨¸Â¡ÇôÀÎ¸¢ÃÐ. 
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Ø ÀÍÅ¢ý §Ã¡ºÉõ ÁÕóÐ¸Ç¢ø ¨¸Â¡ÇôÀÎÅ¨¾ 
"ºòÐìÌ§Ç ¿øÖ §Ã¡º¨É ¿¢ð¸ó¾¨É 
Â¢ðÊÚòÐ¨Å"   - ±ýÚ ÜÈôÀðÎûÇÐ. 
¨Á§Ã¡ºÉõ: 
"ÅÎÅ¢ø º£Ã¸ ÀÄ¨Á §Ã¡º¨É 
¸ÎÌ §Ã¡¸¢½¢ º¢Å¨¾ Á§É¡º£¨Ä" 
¦ºöÓ¨È: 
¸øÄ£ÃÄ¢ýÚõ ¯üÀò¾¢Â¡¸¢ô À¢ò¾ô¨ÀÂ¢ø §ºÕõ À¢ò¨¾, 
ãýÈ¢¦Ä¡ýÈ¡öî º¡Ã¡Âò¨¾ì ¸ÄóÐ Ó¨ÈôÀÊ º¢Ú¸¨ÅòÐ 
¦ÀÕÁ¡ò¾¢¨Ã¸Ç¡¸ ¯ÕðÊì ¦¸¡ûÇ×õ. 
 
±Õ¨Á, Á¡ý, ¸¡ðÎì ¸ÃÊ, ÁÂ¢ø, Á£ý¸û þ¨Å¸Ç¢ý À¢ò¨¾ 
¯À§Â¡¸¢ôÀÐõ ¯ñÎ. 
Ì½õ: 
"¿£¡¢Æ¢× §Á¸ÍÃ ¿£í¸¡ì ¸Éø§Å¸í 
ÜÈ¢Â×ý Á¡¾í ÌÆó¨¾¸û §¿¡ö- À¡Ã¸Àõ 
Å£Ú¨Å Ý¡¢Ôõ §À¡õ............" 
 
«Ç×: 
Ì¨Æó¨¾¸ÙìÌ ¸ÎÌ À¢ÃÁ¡½õ  
Áü¨È§Â¡ÕìÌ 2 ÌýÈ¢ «Ç× Ó¾ø 5 ÌýÈ¢ 
 
Test for korosona(Bezoar): 
 
´Õ º¢È¢Â °º¢¨Âô ÀØì¸ ¸¡öîº¢, §¸¡§Ã¡º¨ÉÂ¢ø Ìò¾¢ì 
À¢Îí¸¢É¡ø, Áïºû ¿¢ÈôÒ¨¸Ô¼ý °º¢Â¢ý §Áø Áïºû À¾¢Â¢ý ¿øÄ 
ºÃì¦¸ýÚ ¸ñÎì ¦¸¡ûÇ×õ. 
 
The following is the test for ascertaining the purity of the substance. A red hot 
needle pierced through it will be found stained with yellow deposit giving out at the same 
time yellow fumes. 
- T.V.Sambasivampillai,II-1736 
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ÁÕòÐÅ Ó¨È¸Ç¢ø §¸¡§Ã¡ºÉõ: 
 
Ø NfhNuhridia Kiyg;ghypyhtJ> fw;G+uts;sp ,iyr; rhw;wpyhtJ 
mDghdpj;Jf; nfhLf;fr; nrq;fpue;jp jPUk;. 
   
Ø ePh;Nfhitf;F ntw;wpiyr;rhw;wpNy mDghdpj;Jf;nfhLf;fyhk;. fz; 
,Us; ePq;f> ,jid Kiyg;ghypy; ,ioj;Jf; fz;zpypl jPUk;. 
  
Ø itR+hp Neha;f;Ff; NfhNuhridiag; gRk;ghypy; ,ioj;Jf; fhiy khiy 
nfhLj;jy; tof;fk;. kw;Wk; fhiy khj;jpuk; ,ijf; nfhLj;J> khiyapy;> 
Njhy; Rl;l rhk;gy; rpl;bifAld; fye;J nfhLj;jYKz;L. ,g;gbf; 
nfhLj;jypdhy;> ,e;NehapYz;lhk; mjpntg;gk; jzpAnkd;f.  
 
Ø NfhNuhrid> njhz;il Neha;f;Fk; ntg;g Neha;f;Fk; rpwe;jJ. 
 
Ø gtsf;fhy;   ky;ypifapd; ,iy> kpsF> NfhNuhrid ,k;%d;iwAk; 
rhpasT vLj;J miuj;J> khj;jpiu Mf;fp Kiwr; Ruj;jpw;F %d;W jpdk; 
nfhLf;fj; jPUk;. 
 
Ø mr;ruj;jpw;Ff; NfhNuhrid vz;nzia cgNahfpf;f ey;y gyid 
mspf;Fk;. 
 
Ø mk;ikapDila nfhjpg;ig afw;Wk;.  
 
Ø fk;khW ntw;wpiyr;rhw;wpy; mDghdk; nra;J nfhLf;ff; Foe;ijfl;F 
cz;lhFk; ff;fpUky; Kjyhfpa gy fg rk;ke;jkhd ,Ukiy ePf;FtJld; 
ry&gkhff; foptijAk;> gr;ir epwkhff; foptijAk;> euk;Gfspy; Vw;gl;l 
typiaAk; ePf;Fk;.  
 
Ø ,d;Dk; ,e;j NfhNuhrid gpj;j tpfw;gj;jpdhYz;lhd fhkhiy> thA> 
rapj;jpak;> fy;yilg;G> ePuilg;G> ];jPhpfSf;Ff;fhZk; cjpur; rpf;fy; 
Kjypatw;wpw;Fk; rpwe;jjhFk;. 
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Ø Kiyg;ghypy; ciuj;Jf; fz;fSf;Fj; jPl;l gpufhrk; mjpfhpf;Fk;. 
fz;fspYs;s khRf;fis ntspg;gLj;Jk;. ,d;Dk; ckpo;ePhpy; ciuj;J 
NkYf;Fg; G+r ntz;Fl;lk;> fUq;Fl;lk;> gil ,itfs; Nghk;. 
nfhj;Jky;yp ,iyr;rhw;wpy; miuj;Jg; Gz;fSf;Fg; G+r tpiutpy; MWk;.  
 
Ø rptg;G Ks;sq;fpr; rhw;wpy; ciuj;Jf; fz;fSf;Fj; jPl;lf; fz;zPh; Kl;ly; 
ePq;Fk;. ,ijr; rpwpa msthf ePbj;Jr; rhg;gpl;Lf;nfhz;L tUtJld; 
gl;rpfspy; ,iwr;rpia cgNahfpj;Jf;nfhz;Ltur; rhPuk; ,Uk;G NghyhFk;. 
Njfk; ngUf;Fk;.  
fhl;lhl;L NfhNuhridk; 
fhl;lhl;L Nuhridia (Goat Bazoar) ½ (65kp. fpuh) Kjy; 1 Fd;wp 
(130kp.fpuh) tPjk; ghypNyDk; jdpahf NtDk; nfhLj;Jtu> tp\q;fis Kwpf;Fk;. 
jiy> %is> ,Ujak; Kjypa ,uhr cWg;GfSf;F typitAk;> 
gQ;Nre;jphpaq;fSf;F mjpf rf;jpiaAk;> jhJ tph;j;jpiaAk;> Njf gyj;ijAk; 
re;Njh\j;ijAk; cz;Lgz;Zk; rpwg;ghf ,Uja Neha;fisg; Nghf;Fk;.  
1.±Á¾ñ¼ì ÌÇ¢¨¸:  
 «Ç× : ÀÂÈÇ×, §¾ý 
 ¾£Õõ §¿¡ö¸û: Å¢ì¸ø. Àì¸Å¡¾õ, ÌýÁõ, ÍÃí¸û, 13 ºýÉ¢, 
¸ÀÅ¡¾ÍÃõ 
    -º¢ò¾¨Åò¾¢Â ¾¢ÃðÎ, 8. 
2.§¸¡§Ã¡º¨É ¸ñ¼¡Å¢ú¾õ: 
 ¿¡Å¢ø ¾¼Å×õ 
 ¾£Õõ Å¢Â¡¾¢:ºýÉ¢§¾¡¼õ, ¾¡À ÍÃõ, ¿¡ ÅÈðº¢ 
     -À¢ÃÁÓÉ¢ ¨Åò¾¢Â º¡ì¸¢Ãõ À¡¸õ 1 
3.NfhNuhrid khj;jpiu 
msT:  Fd;wp msT  khj;jpiu Kiyg;ghy;. 
 ¾£Õõ Å¢Â¡¾¢: Nrj;Jk Neha;fs;> rd;dp> ePh;j; Njhlq;fs;> kaf;fk;> rpNyj;Jk Ruk; 
ePq;Fk;.,k;khj;jpiuia mz;lj; ijyj;jpy; nfhLf;f typg;gprpT ePq;Fk;.  
      -Ì½À¡¼õ ¾¡Ð ƒ£Å ÅÌôÒ 
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4.«Ó÷¾¡¾¢ì ÌÇ¢¨¸: 
 «Ç×: ÌýÈ¢, Á¡º¢Àò¾¢Ã¢ì ÌÊ¿£÷ 
¾£Õõ §¿¡ö¸û: Á¡ó¾õ, Å¡ó¾¢, Ì¼üÀÎÅý, ¸ÃôÀ¡ý, ¯ôÀ¢ºõ, 
þÕÁø 
-º¢ò¾¨Åò¾¢Â ¾¢ÃðÎ, 2 
5. .§¸¡§Ã¡º¨É ¨¾Äõ: 
¾¨Ä ÓØ¸¢¼, ºýÉ¢, ¦Åð¨¼, ¿£Ã¡õÀø, ¸¢Ã¡½¢, ÌýÁõ, ¦º¡È¢, À¢ò¾õ 
¾£Õõ. 
     -¾ýÅó¾¢Ã¢ ¨¾Äõ, 1 
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POORAM 
(Mercurous chloride) 
 
Introduction: 
 
Mercury(I) chloride is the chemical compound with the formula Hg2Cl2. Also known as 
calomel (a mineral form, rarely found in nature) or mercurous chloride, this dense white or 
yellowish-white, odourless solid is the principal example of a mercury(I) compound. It is a 
component of reference electrodes in electrochemistry.  
 
A relatively rare mineral, associated with other mercury minerals, probably always 
secondary and late in the mineral sequence. It will be found in small brilliant crystals in cavities, 
associated with cinnabar and often perched on crystals of that mercury ore.  
 
Two related anhydrous halides are similar in color to calomel even though they contain 
copper. Rare nantokite (CuCl; copper chloride) and almost as rare marshite (CuI; copper iodide) 
are the only colorless or white copper minerals. Both are tetrahedral. Marshite forms triangular 
lustrous tetrahedral crystals at Chuquicamata, Chile, and was formerly found at Broken Hill, New 
South Wales. In a mine tunnel near Chuquicamata, iron-stained orange incrustations of marshite, 
catalyzed by iron rails and bolts, form from drainage water.  
 
Marshite is colorless to pale yellow when fresh, as a rule, but seems to turn coppery on 
exposure to light and air. Iodine vapors emanate when a sealed marshite container is opened, and 
can be smelled; perhaps copper is freed and remains to give the color noted in older exposed 
specimens.  
 
History: 
The name calomel is thought to come from the Greek word beautiful, and black. This 
name (somewhat surprising for a white compound) is probably due to its characteristic 
disproportionation reaction with ammonia, which gives a spectacular black coloration due to  
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the finely dispersed metallic mercury formed. It is also referred to as the mineral horn quicksilver 
or horn mercury. Calomel was taken internally and used as a laxative and disinfectant, as well as 
in the treatment of syphilis, until the early 20th century. 
Mercury became a popular remedy for a variety of physical and mental ailments during 
the age of "heroic medicine." It was used by doctors in America throughout the 18th century, and 
during the revolution, to make patients regurgitate and release their body from "impurities". 
Benjamin Rush, a famed physician in colonial Philadelphia and signatory to the Declaration of 
Independence, was one particular well-known advocate of mercury in medicine and famously 
used calomel to treat sufferers of yellow fever during its outbreak in the city in 1793. Calomel was 
given to patients as a purgative until they began to salivate. However, it was often administered to 
patients in such great quantities that their hair and teeth fell out. 
 
Preparation and Reactions: 
Mercurous chloride forms by the reaction of elemental mercury and mercuric chlorid 
Hg + HgCl2 → Hg2Cl2 
It can be prepared via metathesis reaction involving aqueous mercury(I) nitrate using various  
chloride sources including NaCl or HCl 
2HCl + Hg2(NO3)2 → Hg2Cl2 + 2HNO3 
Ammonia causes Hg2Cl2 to disproportionate: 
Hg2Cl2 + 2NH3 → Hg + Hg(NH2)Cl + NH4Cl 
 
Photochemistry: 
Mercurous chloride decomposes into mercury(II) chloride and elemental mercury upon exposure 
to UV light 
Hg2Cl2 → HgCl2 + Hg 
The formation of Hg can be used to calculate the number of photons in the light beam, by 
the technique of actinometry. By utilizing a light reaction in the presence of mercury(II) chloride 
and ammonium oxalate, mercury(I) chloride, ammonium chloride and carbon dioxide is 
produced. 
2HgCl2 + (NH4)2C2O4 + Light → Hg2Cl2(s) + 2[NH4+][Cl−] + 2CO2  
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Physical and Chemical Properties: 
Molecular formula     Hg2Cl2 
Molar mass                 472.09 g/mol 
Appearance                White solid 
Density                       7.150 g/cm3 
Melting point              525 °C (triple point) 
Boiling point               383 °C (sublimes) 
Solubility in water      0.2 mg/100 mL 
Solubility                    Insoluble in ethanol, ether 
Refractive index (nD)  1.973 
 
Related Compounds: 
Other anions                 Mercury(I) fluoride 
                                      Mercury(I) bromide 
                                      Mercury(I) iodide 
Other cations                 Mercury(II) chloride 
 
Stability and Reactivity: 
 
Stability: 
Stable under ordinary conditions of use and storage. Slowly decomposed by sunlight into 
mercuric chloride and metallic mercury.  
 
Hazardous Decomposition Products:  
Oxides of the contained metal and halogen, possibly also free, or ionic halogen.  
 
Hazardous Polymerization:  
Will not occur.  
 
Incompatibilities:  
  Bromides, iodides, ammonia, alkalis, cyanides, chlorides, copper and lead salts, silver 
salts, carbonates, sulfides, soap, lime water, iodoform, and hydrogen peroxide.  
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Conditions to Avoid:  
 Light and incompatibles.  
 
Handling and Storage: 
 Keep in a tightly closed container, stored in a cool, dry, ventilated area. Protect against  
physical damage. Isolate from any source of heat or ignition. Protect from light. Follow strict 
hygiene practices. Containers of this material may be hazardous when empty since they retain 
product residues (dust, solids); observe all warnings and precautions listed for the product. 
 
POISONOUS EFFECTS OF POORAM 
Potential Health Effects:  
Inhalation:   
Causes irritation to the respiratory tract. Symptoms include sore throat, coughing, 
pain, tightness in chest, breathing difficulties, shortness of breath and headache. 
Pneumonitis may develop. Can be absorbed through inhalation with symptoms to parallel 
ingestion. 
Ingestion:  
Toxic! Average lethal dose for inorganic mercury salts is about 1 gram. May 
cause burning of the mouth and pharynx, abdominal pain, vomiting, bloody diarrhea. May 
be followed by a rapid and weak pulse, shallow breathing, paleness, exhaustion, tremors 
and collapse. Delayed death may occur from renal failure. 
Skin Contact: 
Causes irritation. Symptoms include redness and pain. May cause burns. May 
cause sensitization. Can be absorbed through the skin with symptoms to parallel 
ingestion.  
Eye Contact:   
Causes irritation to eyes, may cause burns and eye damage.  
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Chronic Exposure: 
Chronic exposure through any route can produce central nervous system damage.  
May cause muscle tremors, personality and behavior changes, memory loss, metallic 
taste, loosening of the teeth, digestive disorders, skin rashes, brain damage and kidney 
damage.  
Can cause skin allergies and accumulate in the body. Repeated skin contact can 
cause the skin to turn grey in color. Not a known reproductive hazard, but related mercury 
compounds can damage the developing fetus and decrease fertility in males and females. 
Aggravation of Pre-existing Conditions: 
Persons with nervous disorders, or impaired kidney or respiratory function, or a 
history of allergies or a known sensitization to mercury may be more susceptible to the 
effects of the substance. 
Toxicological Information of Pooram: 
Toxicological Data:  
 Oral rat LD50: 210 mg/kg.  
 
Reproductive Toxicity:  
All forms of mercury can cross the placenta to the fetus, but most of what is known has 
been learned from experimental animals. 
 
Calomel Therapeutic Application:  
 
Ø Calomel is peculiarly called for as a purgative, whenever, in connection with another demand  
for cathartic medicine, there is an indication for stimulating the secretory function of the liver. 
Ø Full mercurial purgation will generally entirely relieve this affection, and probably prevent the 
occurrence of some more serious attack, as bilious colic, cholera morbus, dysentery, or 
jaundice. 
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Ø In all cases of constipation, with deficiency of bile in the passages, a purgative dose of 
calomel may be given. This condition often precedes an attack of jaundice, which may thus 
be prevented. 
Ø In jaundice itself, of the ordinary kind, attended with clay-coloured passages, and bilious 
urine, a purgative dose of calomel, alone or combined, should be given at the 
commencement, and occasionally repeated in the course of the disease. 
Ø Acute hepatitis generally offers the same indication. Where a purgative is required, calomel 
should almost always be used, either alone, or connected with other cathartics. in the chronic 
variety, active purgation is seldom desirable, and it is rather the alterative than the cathartic 
action of the medicine that is wanted. 
Ø In acute splenitis, calomel should be given at the outset, with a view to deplete from the portal 
circle, so intimately connected with that organ. 
Ø In bilious colic, calomel is strongly called for by the congested state of the liver, and, in 
conjunction with opium, is the most important remedy in the disease. 
Ø In gastritis, severe enteritis, and peritonitis, calomel may often be advantageously used as a  
cathartic, at the commencement of the disease.  
Ø In infantile diseases, calomel is peculiarly efficacious. it is recommended here by its want of 
unpleasant taste, by its retention upon the stomach when others are rejected, and by the 
general mildness of its operation. it is useful, moreover, in the complaints of children. 
Ø In epidemic cholera, dysentery, yellow fever, etc., it has been recommended in large doses as 
a sedative agent. it is asserted that, when given very largely in these cases, so far from causing 
local or general excitement, it produces, on the contrary, a remarkable sedative effect, allaying 
the local irritation, checking vomiting and purging, lowering the frequency and force of the 
pulse and the heat of skin, and greatly contributing to the cure. 
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Plumbago Zeylanica 
Family : Plumbaginoaceae 
Hindi : Kala-chitra 
Sans : Chidraka 
Malai : Nalla chitra mullam 
Kan : Nila chitramua 
 
Chemical Constituents of The Aerial Parts of Plumbago Zeylanica: 
  Plumbagin, 
   Isoshinanolone, 
   Plumbagic acid , 
   Beta-sitosterol,  
  4-Hydroxybenzaldehyde , 
   Trans-Cinnamic Acid, 
   Vanillic Acid, 
   2, 5-Dimethyl-7-Hydroxychromone, 
   Indole-3-Carboxaldehyde. 
-PMID:17727061 
Medicinal Uses: 
 
Ø In Ayurved root is useful in dyspepsia, piles, ana-sarca, diarrhea, skin diseases.   
A tincture of the root-bark is employed as an antiperiodic. 
Ø Root has a beneficial effect on piles; in these cases it is given in various 
combinations; e.g., an earthen jar or pot of which the inside is lined with a paste of 
the root is used for preparing curds (dadhi or Kanjica) which is given to persons 
suffering from heamorrhoids and prurigo. Root was employed in the treatment of 
intermittent fevers. 
Ø It acts as a powerful sudorific - (Dymock). For chronic and muscular rheumatism 
and all painful affections of the joints. 
Ø For epilepsy, hysteria, mania and other mental disorders a compound powder 
com-posed of Chiraka root, Brahmi and Acorus calamus is useful in doses of 10 to 
30 grains three times a day. 
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Pharmacological Activity: 
 
An antileishmanial prenyloxy-naphthoquinone from roots of Plumbago zeylanica. 
 This study discloses strong in vitro antileishmanial activity of  2-methyl-5±-(3'-
methyl-but-2'-enyloxy)-[1,4]naphthoquinone , a prenyloxy-naphthoquinone isolated and 
characterised from roots of the plant Plumbago zeylanica . 
- Planta Med. 1971 ul;20(1):8-13. 
The constituents in the roots of Plumbago auriculata Lam. and Plumbago zeylanica 
L. responsible for antibacterial activity.  
Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer 
cells in vitro through the NF-κB signaling pathway. 
-PMID: 5154609 
 To investigate the effects and underlying mechanisms of plumbagin, a 
naphthoquinone derived from medicinal plant Plumbago zeylanica, on human gastric 
cancer (GC) cells. 
 Plumbagin inhibits cell growth and potentiates apoptosis in human GC cells 
through the NF-κB pathway. 
 
PLUMBAGO ZEYLANICA POISONOUS EFFECTS 
 
ACUTE HEALTH EFFECTS OF PLUMBAGIN: 
SWALLOWED: 
 
Ø Toxic effects may result from the accidental ingestion of it.  Animal experiments 
indicate that ingestion of less than 40 gram may be fatal or may produce serious 
damage to the health of the individual. 
Ø It can produce chemical burns within the oral cavity and gastrointestinal tract 
following ingestion. 
Ø The material can produce severe chemical burns within the oral cavity and 
gastrointestinal tract following ingestion. 
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EYE: 
 
Ø It can produce chemical burns to the eye following direct contact. Vapors or mists 
may be extremely irritating.  
Ø It can produce severe chemical burns to the eye following direct contact. Vapors 
or mists may be extremely irritating. 
Ø If applied to the eyes, it causes severe eye damage. 
 
SKIN 
 
Ø It can produce chemical burns following direct contact with the skin. 
Ø It can produce severe chemical burns following direct contact with the skin. 
Ø Skin contact with it may damage the health of the individual; systemic effects may 
result following absorption. 
Ø Open cuts, abraded or irritated skin should not be exposed to this material. Entry 
into the blood-stream, through, for example, cuts, abrasions or lesions, may 
produce systemic injury with harmful effects.  
  
INHALED: 
 
Ø It can cause respiratory irritation in some persons. The body's response to such 
irritation can cause further lung damage. 
Ø Inhalation of dusts, generated by it during the course of normal handling, may 
produce serious damage to the health of the Individual. 
Ø Persons with impaired respiratory function, airway diseases and conditions such 
as emphysema or chronic bronchitis, may incur further disability if excessive 
concentrations of particulate are inhaled. 
Ø High concentrations cause inflamed airways and watery swelling of the lungs with 
edema. 
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PTYCHOTIS AJOWAN, DC., 
(Carum copticum; P. coptica; Carum roxburghianum or  
P. roxburghianum; (Benth); Ammi copticum. 
 
 
Family  :  Unbelliferae 
Sans   : Yavanika; Ajmada;  
Eng   :  Bishop’s weed;  
Omum (seeds) :  Lovage; Ajawa Seeds.  
Hind & Duk  : Ajowan. 
 
Habitat 
This plant (Carum Copticum) grows and is largely cultivated in Eastern India, 
Particularly abundant in and around Indore and the Nizam’s Dominions. 
 
Part Used :  Fruit. 
Constituents: 
An aromatic volatile essential oil and a crystalline substance-s earoptin, which 
collects on the surface of the distilled water; also cumene and terpene, “thymine”.  
 “The seeds of Carum copticum contain the antiseptic thymol and they yield 2 to 3 
percent of an essential oil which is official as ‘oil of aiowan’ which contains not less than 
40 to 50 percent of thymol.”. 
-(Chopra’s “I.D. of Ip. 82). 
 
Action   Seeds possess diffusible stimulant,  
   Stomachic,  
   Carminative,  
   Tonic,    
   Aromatic,  
   Pungent,  
   Antispasmodic  
Anthelmintic 
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Uses: 
Ø Omum seeds are useful in flatulence, indigestion, colic, atonic dyspepsia, 
diarrhea, cholera, hysteria and spasmodic affections of the bowels, and check 
chronic discharges such as profuse expectoration in bronchitis.  
Ø Vola-tile oil is also used in cholera, flatulent, colic, atonic dyspepsia or diarrhea, 
hysteria and indigestion. Externally it is applied to relieve rheumatic and neuralgic 
pains.  
Ø “The chief importance of ajowan seeds is for production of thymol, which is a 
very valuable anthelmintic”.  
Ø Seeds are used also as spices along with betel-nuts and pan leaves in flatulence, 
dyspepsia and spasmodic affections.  
Ø A plaster of poultice or the crushed seeds is used to relieve the pain of colic.  
Ø Omum seds made hot are used as a dry fomentation to the chest in asthma and to 
the hands and feet in cholera, fainting, syncope, and rheumatism. 
 
Pharmacological activity: 
 
Studies on the antihypertensive, antispasmodic, bronchodilator and 
hepatoprotective activities of the Carum copticum seed extract. 
 
This study describes the antihypertensive, antispasmodic, bronchodilator and 
hepatoprotective activities of the aqueous-methanolic extract of Carum copticum Benth.  
These results indicate the presence of calcium antagonist(s) in Carum copticum seeds and 
thus provides sound mechanistic basis for some of their folkloric uses 
 - http://dx.doi.org/10.1016/j.jep.2005.01.017, How to Cite or Link Using DOI 
 
Anticonvulsant and depressant effects of aqueous extracts of Carum copticum seeds 
in male rats. 
 In this study, the effects of aqueous extracts of Carum copticum seeds (CCS) were 
evaluated in kindling models of epilepsy. These results suggest that CCS extract has 
remarkable antiepileptic and central depressant effects. 
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- Rezvani ME, Roohbakhsh A, Mosaddegh MH, Esmailidehaj M, Khaloobagheri 
F, Department of  Physiology, School of Medicine, Shahid Sadoughi University of 
Medical Sciences, Yazd, Iran. erezvani@yahoo.com 
 
Antitussive effect of Carum copticum in Guinea pigs 
 
Several therapeutic effects including anti-asthma and dyspnea have been 
described for the seeds of Carum copticum In previous studies the relaxant and 
anticholinergic (functional antagonism) effects, histamine (H(1)) inhibitory effect of 
Carum copticum have been demonstrated on guinea pig tracheal chains. In the present 
study the antitussive effect of this plant was evaluated. 
 
The results showed significant reduction of cough number obtained in the 
presence of both concentration. 
- Boskabady MH, Jandaghi P, Kiani S, Hasanzadeh L. Department of 
Physiology, Ghaem Medical Centre, Mashhad University of Medical 
Sciences, Post Code 91735, Mashhad, Iran. mhboskabady@mums.ac.ir 
 
The analgesic effect of Carum copticum extract and morphine on phasic pain in mice 
Carum copticum (L.) Sprague ex Turrill is a plant in Umbelliferae family, which 
is mentioned to have some therapeutic effects on headache and joint pains in traditional 
literature, but there are not enough scientific reports to prove its effects on pain.  
So, we conducted to design an experimental clinical trial study to assess and 
compare the analgesic effect of ethanolic extract of Carum copticum fruit with morphine 
by using a tail-flick analgesiometer device. Our results indicate that the test drug 
produced significant increase in tail-flick latency (TFL) during 2 h post-drug 
administration (p < 0.05) 
 
The present study supports the claims of traditional medicine showing 
that Carum copticum extract possesses a clear-cut analgesic effect.  
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Role of Carum copticum seeds in modulating chromium-induced toxicity on human 
bronchial epithelial cells and human peripheral blood lymphocytes. 
 
The present study pertains to investigate modulatory effects of methanolic extract 
of C. copticum seeds (MCE) against hexavalent chromium induced cytotoxicity, 
genotoxicity, apoptosis and oxidative stress on human bronchial epithelial cells (BEAS-
2B) and isolated human peripheral blood lymphocyte (PBL) in vitro.  
This study provides strong evidence to support the beneficial effect of MCE in 
preventing Cr(VI) induced toxicity in BEAS-2B and PBL cells 
- Exp Toxicol Pathol. 2012 Nov;64(7-8):889-97. doi: 10.1016/j.etp.2011.03.012. 
Epub 2011 Apr 22. 
 
The analgesic effect of Carum copticum extract and morphine 
on phasic pain in mice 
The present study supports the claims of Iranian traditional medicine showing 
that Carum copticum extract possesses a clear-cut analgesic effect. 
- Journal of Ethnopharmacology 109 (2007) 226–228 
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BORASSUS FLABELLIFER, Linn. 
 
Family :  Palmae 
Sans  : Tala. 
Eng  : Palmyra palm; Brab tree.  
Hind  : Taltar 
Habitat : 
Ø The palmyra palm is a large tree up to 30m high and the trunk may 
have a circumference of 1.7m at the base. 
Ø The palmyra palm is a large tree up to 30m high and the trunk may have a 
circumference of 1.7m at the base. There may be 25-40 fresh leaves.  
Ø It is commonly cultivated in India, Southeast Asia, Malaysia and occasionally in 
other warm regions including Hawaii and southern Florida. In India, it is planted 
as a windbreak on the plains.  
Ø Grows on dry soils or sandy localities along river banks, throughout tropical India, 
especially in South India. 
-  Economic Botany (1988) 42(3) 420-441 
Parts Used :  Root, Flowering Stalk, Juice, Bark and Fruit. 
 
Constituents :  Gum,  
Fat , 
Albuminoids. 
Action :  
Ø Root is cooling and restorative; juice is diuretic, cooling, stimulant and 
antiphlogistic when fresh;  
Ø Pulp from the unripe fruit is diuretic, demulcent and nutritive; terminal buds are 
nutritive and diuretic. 
 
Preparations :  
Ø Palm juice and palm-wine, Confection.  
Ø sago from the trunk; poultice; pulp; ashes of the flowering-stalk and decoction. 
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Uses 
Ø It is from the juice of this tree that toddy, jiggery and country-sugar are prepared 
in large quantities in Southern India. 
Ø Sugar-candy produced in the manufacture of sugar from the palm is used in cough 
and pulmonary affections. 
Ø Fresh saccharine juice obtained by excision of the spadis (young terminal buds) 
early in the morning is cooling and is a stimulant beverage, also acts as a laxative 
taken regularly for several mornings. 
Ø It is useful for inflame-matory affections and dropsy; also in gastric catarrh and to 
check hiccup; as diuretic it is useful in gonorrhea. 
Ø “Decoction of the root is also used in gastritis and hiccup.”, Slighty fermented 
juice called Tari (toddy),” an intoxicating liquor, is a favourite drink among the 
laboring classes” is given in dibetes. 
Ø With aromatics it is a good tonic in emaciation or phthisis. Milky fluid from the 
immature fruits is a sweet and cooling drink, and checks hiccup and sickness. 
Ø Toddy poulice prepared by adding fresh drawn toddy to rice flour and subjected to 
a gentle fire till fermentation takes place, then spread on a cloth forms a valuable 
stimulant application to in-flamed parts, gangrenous and indolent ulcers, 
carbuncles etc. 
Ø Yellow pulp surrounding the ripe nuts is sweet, but heavy and indigestible. Ashes 
of the flowering stalk are useful in enlarged spleen. 
Ø Bark of the tree burnt, reduced to charcoal and pulverized makes a good 
dentifrice; decoration of the bark with a little salt added to it is good astringent 
gargle for strengthening gums and teeth. 
Ø The palm yields a fruit which is eaten with much relish. 
 
Toddy 
The chief product of the palmyra is the sweet sap (toddy) obtained by tapping the 
tip of the inflorescence, as is done with the other sugar. 
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Jaggery Preparation: 
Unrefined sugar made from palm sap. 
- American Heritage® Dictionary of the English Language, Fourth Edition 
 It is the first extract of the palm juice.  
Ø The juice is boiled, a little salt is added to it to act as a preservative, and so that the 
jaggery does not taste too sweet.  
Ø It is cooled and poured into a long cone made of palm leaves. 
Ø Jaggery is an amorphous form of unrefined and non-distilled sugar repared from sap 
or juice of plants which contain considerable amount of sucrose or sugar in them, like 
sugar cane and palms like date palm and Palmyra 
        -www.medindia.net 
 
Constituents: 
Palmyra palm jaggery (gur) is much more nutritious than crude cane sugar, 
containing  
1.04% protein,  
0.19% fat,  
76.86% sucrose, 
1.66% glucose,  
3.15% total minerals,  
0.861 % calcium,  
0.052%  phosphorus;  
also 11.01 mg iron per 100 g  
0.767 mg of copper per 100 g.  
The fresh sap is reportedly a good source of vitamin B complex. 
- Economic Botany (1988) 42(3) 420-441Types of Jaggery:   
 
1. Sugarcane Jaggery:  
Colour : Golden Brown to Dark Brown. 
Preparation: Prepared by boiling Sugar Cane juice. 
Physical State: Amorphous solid to viscous granular liquid. 
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2. Date Palm Jaggery: 
Colour : Golden Brown to Dark Brown. 
Preparation: Prepared by boiling sap of Date Palm. 
Physical State: Amorphous solid and viscous granular to clear red liquid. 
 
3. Palmyra Jaggery:  
Colour  : Off white to pale yellowish white.  
Preparation  : Prepared by boiling sap of Palmyra Palm.  
Physical State : Amorphous solid.  
 
4. Toddy Palm Jaggery:  
Colour  : Golden Brown.  
Preparation  : Prepared by boiling sap of Toddy Palm.  
Physical State : Amorphous solid.  
 
5. Other Palm Jaggery:  
These days, even the sap of Sago Palm and Coconut Palm are also being used to 
make Jaggery, but they are rarely 
 
Nutritive value of 100 gm of paim Jaggery: 
 
 Energry  -  349 Ecals               
 Moisture  - 9 gm                                     
  Protein(gm)  - 2 gm                             
 Fat(gm)  - 0 gm                                  
 Mineral(gm)  -  4 gm                                                             
 Carbohydrates(gm)  -  85 gm                     
 Calcium(mg)  -  1252 mg                          
 Phosphorous(mg)  - 372  mg                               
                             - dir.indiamart.com 
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BEZOAR 
Eng : Serpent stone; gall-stone.  
Pers : Hajaratalbaqr; Gaorohan.  
Hind : Gorochan.  
Tel : Gorochanamu.  
Tam. : Gorochana 
  
Ø It is a concretion found in the stomach and in the gall-bladder of an ox or cow and 
occurs as light, yellowish or green, solid or spherical concretions.  
 In Hindu medicine it is highly prized and extensively used. 
Ø Dose is 1/6th to 1/4th grain.  
Ø It is cooling, and aromatic. Prescribed is miscarriage. Artificial Bezoar is a 
substance made up of ox gall mixed with hair, wood, magnesia, phosphate of 
lime, pipe clay, etc. 
 
  
 
 
47 
 
FEL BOVIS 
Eng. Name :  Fresh ox gall 
The fresh ox gall secreted by the liver and collected in the gall-bladder. 
Ø It is a dark or yellowish green viscid liquid of a peculiar unpleasant odour and 
bitterish taste. It is neutral or faintly alkaline in reaction, soluble in water and 
alcohol. 
 
FEL BOVINUM PURIFCATUM or FEL TAURI DEPURATUS 
Eng    : Purified ox-gall or ox-bile.  
Sans    : Gorochanam.  
Arab   : Hajr-ul-bahr.  
Hind   : Zehar-mohra. Duk.  
Mah. Kon. & Can : Gorochana.  
Guj   : Guruchandan.  
Tam   ; Gorojanai.  
Tel   ; Gorojanam.  
Sinh   : Visagul.  
English  : Cow  Gallstone, Ox Gallstone 
Latin   :  Calculus  Bovis seu  Bubali 
Pharmaceutical Name :  Calculus Bovis 
 
Ø Burm.-Goyazin is prepared by evaporating ox-gall to one-third, adding alcohol, 
filtering, distilling off and evaporating until it acquires a suitable consistence for 
making pills. Gorochanam is light and can be easily broken between the fingers. It 
is laxative, anti-spasmodic, chlagogue, cooling are aromatic.  
Ø It is specially indicated in measles and small - pox, to reduce excessive heat\in the 
body; also in whooping cough and watery stools and choleric symptoms.  
Ø It is used in convulsions, hysteria, spasmodic diseases, melancholia and intestinal 
disorders with deficient secretion of bile, in jaundice, etc., and in abortion.  
Ø It is given to infants for stopping green stools and (in small doses) as a laxative. 
The usual adult dose is from 5 to 10 grains.  
Ø It enters into the composition of some medicines used for skin diseases. 
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Method for Pharmaceutical Preparations:  
Ø The gallstone of an ox is collected in any season, or the bile of an ox. After gathering, the 
material is dried and made into powder or pills. 
  
Properties: Bitter and cool 
 
Functions:  
Ø To clear heat and release toxins 
Ø To eliminate endogenous wind and stop convulsions. 
Ø To resolve phlegm and promote resuscitation 
 
Indications: 
Ø Loss of consciousness and convulsions caused by high fever.  
Ø Sore throat or ulcers and boils due to accumulation of toxic heat. 
 
Cautions   : This substance is contraindicated during pregnancy. 
      - ccbolgroup.com/calculosE.html 
 
Chemical constituents: 
Ø It is chemically similar to human bile, so it has seen widespread use in traditional 
medicine in various cultures.  
Ø After processing for medical use, this substance can be used to assist the body in the 
breaking down of fats and the assimilation of vitamins A, D, E, and K. It also helps treat 
constipation, and prevent gallstones and certain liver diseases, such as cirrhosis. 
Ø Ox bile primarily consists of water, salts, pigments, cholesterol, lecithin, and several ions, 
and it is chemically similar to human bile, making it readily compatible for medical 
purposes.  The use of it in extract form has shown benefit in situations where the liver 
is not functioning properly and is unable to adequately produce enough bile itself. 
Ø The extract can assist in the assimilation of fat-soluble vitamins, and it also may help in 
situations of slow colon motility, obstructions of the gallbladder, and cholecystectomy. 
-www.wisegeek.org  
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Benefits of ox bile extract 
Ø Assists in metabolizing cholesterol and fat 
Ø Facilitates absorption of vitamins K, A, D and E 
Ø May help prevent gallstones 
Ø May help moderate cholesterol and triglycerides 
Ø May be beneficial in treating liver diseases such as cirrhosis and hepatitis 
Supplemental bile extract helps emulsify fats and promotes absorption of fat-
soluble vitamins such as vitamins K, A, D and E. 
       - www.dermaharmony.com 
Side Effects: 
Ø Some indicated side effects of ox bile extract are nausea, upset stomach and 
diarrhea, often a result of exceeding the recommended dosage. Possible allergic 
reactions may occur in those sensitive to it. 
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4.1. COLLECTION, IDENTIFICATION, PURIFICATION AND 
PREPARATION OF MEDICINE 
 
COLLECTION OF DRUG: 
The raw drug was procured from country drug merchant shop, Chennai and 
Nagarkovil. 
 
AUTHENTICATION: 
The raw drug Pooram was authenticated by Siddha Central Research Institute, 
Chennai.  
The raw drug of plants were authenticated by Department of Botany, NIS, 
Chennnai. 
 
METHOD OF PURIFICATION: 
 
PURIFICATION OF  POORAM (CALOMEL):  
 
        Pooram is kept in mud plate in heat and add quarter liter of Mukia 
maderaspatana juice drop by drop. On Completion of this, milk is gently added into it. 
Dust particle on the outer area of Pooram is removed and then Pooram is sepearted for 
usage. 
      - Anuboga Vaidhya Navaneedham part 4, P-92) 
 
PURIFICATION OF SITHIRAMOOLAM (PLUMBAGO INDICA):  
 
 The roots are pounded well and made into powder. 
- vaithiya sinthamani, P-118. 
PURIFICATION OF OMAM (BISHOPS WEED):  
           The seeds are soaked in supernatant of limestone solution for the samam (3 hours) 
and dried well.                   
 - vaithiya sinthamani, P-118  
 
PURIFICATION OF  KOROSANAM (BEZOAR):  
   
  Dust, stones and dander are removed.  
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PURIFICATION OF PANAIVELLAM  (JAGGERY): 
 
Dust, stones and dander are removed.  
  
METHOD OF PREPARATION:  
INGREDIENTS: 
 Chithiramoola verpattai chooranam (Plumbago indica) :   1.25varagan (5.25gms) 
 purified rasakarpooram  ( Mercurous chloride)              :    1.25varagan (5.25gms 
 Ooma chooranam (Carum copticum)  :    1.25varagan (5.25gms) 
  Korosanai  (Ox bile)  :    1.25varagan (5.25gms) 
Panaivellam  (Jaggery)                                                    :    3.45varagan (14 gms) 
 
 Purified Mercurous chloride, Purified Powder of Plumbago indica, Purified 
Powder of Carum copticum are ground well in mortar for 1 hour. To this Purified Jaggery 
and Ox bile are added, these are again ground for 6 hours and rolled into a pepper sized 
(56mg)  pills.  
 
Dose of drug           :    One to One and Half  pills (56mg to 84mg), two times a day. 
Adjuvant                 :    Sugar/ Paste of dried ginger / Butter                          
Duration                  :    10 days  
Therapeutic uses     :  Parpala viranangal, Kiranthi rogangal, Yoniputru, Soolaigal, 
Kallippukiranthi, Lingaputru, Pouthirarogangal, Kannappilavai, Pakappilavai, 
Marsilanthi, Vippuruthi, 8 vagai gunmam, Maega ranangal. 
 
- Ref: Veeramaamunivar vagadathiratu part I; Page No-49; Editio - 1994  
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Á¡ò¾¢¨Ã  
 
 
Ø µ§Ã «ÇÅ¡¸ì ¦¸¡Îì¸ §ÅñÊÂ ÁÕóÐì ¸Ä¨Å Á¡ò¾¢¨Ã 
±ÉôÀÎõ   ¯Õñ¨¼¸Ç¡¸ ¯ûÇ¾¡ø ¯Õñ¨¼ ±ÉôÀÎõ. 
 
Ø ¾ð¨¼Â¡¸ þÕôÀ¾¡ø Å¢ø¨Ä ±ÉôÀÎõ. ¦À¡ÐÅ¡¸ ÌÇ¢¨¸ ±ýÚõ 
ÌÈ¢ôÀ¢¼ôÀÎõ. 
 
Ø Á¡ò¾¢¨Ã ¦ºöÅ¾üÌ¡¢Â ºÃìÌ¸¨Ç ¾É¢ò¾É¢Â¡¸ ¦À¡ÊÂ¡¸ ¬ì¸¢ì 
¦¸¡ûÇ §ÅñÎõ. À¢ÃÌ «Ç×ôÀÊ ´ýÚ §º÷òÐì ¦¸¡ûÇ 
§ÅñÎõ. ÁÕóÐîºÃìÌ À¢ÍÀ¢ÍôÒûÇ ºÃìÌì¸û þøÄ¡Å¢ð¼¡ø 
º¢È¢Ð À¢º¢ý §º÷ò¾¡ø Á¡ò¾¢¨Ã ¯ÕðÎÅ¾üÌ Åº¾¢Â¡¸ þÕìÌõ. 
 
Ø ãÄ¢¨¸îº¡Ú, À¡ø, À¢º¢ý, Ó¾Ä¢Â¨Å §º÷òÐ ¸øÅò¾¢ø ¿ýÈ¡¸ 
«¨Ãì¸ §ÅñÎõ. ¸Šà¡¢, «õÀ÷, §¸¡§Ã¡º¨É, ÌíÌÁôâ §À¡ýÈ 
Å¡º¨Éô ¦À¡Õð¸¨Ç ¸¨¼º¢Â¢ø «¨ÃôÀ§¾ º¢Èó¾Ð. 
 
Ø ÒðÊÂ¢ý «ÊÂ¢ø º¢È¢¾Ç× ÀïÍ «øÄÐ ÀÕò¾¢ò Ð½¢¨Âô ÀÃôÀ¢ 
Á¡ò¾¢¨Ã¸¨Ç ¨ÅôÀÐ ¿øÄÐ. 
-ÒÄ¢ôÀ¡½¢ ¨Åò¾¢Âõ 10 
 
Ø Á¡ò¾¢¨Ã¸¨Ç ¯ÙóÐ, º¢ÚÀÂ¢Ú, ¾ð¨¼, ¿£Úò¾¢¡¢ Ó¾Ä¢Â 
ÅÊÅí¸Ç¢ø ¯ÕðÊì ¦¸¡ûÇ §ÅñÎõ. ¿¢ÆÄ¢ø ¯Ä÷ò¾¢ ¿ýÈ¡¸ 
ã¼ìÜÊÂ ÒðÊÂ¢ø Àò¾¢ÃôÀÎò¾ §ÅñÎõ.  
-À¢ÃÁÓÉ¢ ÁÕòÐÅ Å¢Çì¸õ 5 
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Unpurified Pooram                                          Purified Pooram 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
Kodi Veli  Omam 
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               Panai Vellam                                                    Korosanam 
 
 
 
 
 
 
 
 
 
SIDDHAR KULIKAI 
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4.2. QUALITATIVE ANALYSIS 
 
PHYSICO-CHEMICAL PROPERTIES  SIDDHAR KULIKAI 
 
 COLOUR  
About 50 gm of Siddhar Kulikai was taken in a clean glass beaker and tested for its colour 
by viewing against a white opaque back ground  under direct sunlight. 
 
ODOUR 
About 50 gm of the Siddhar Kulikai was placed in 100 ml of beaker and tested for its 
odour by wafting the air above the beaker. 
 
pH 
The ph of the Siddhar Kulikai was estimated as per the method prescribed in the Indian 
standard (IS) - 6940(1982). One gram of the  Siddhar Kulikai was taken into a 100ml graduated 
cylinder containing about 50 ml of water and filled up to the mark with water. The cylinder 
 was stopped and shaken vigorously for two minutes and the suspension was allowed to 
settle for an hour at 25 to 27˚c. About 25 ml of the clear aqueous solution was transferred into a 
50 ml beaker and tested for pH using DIGISUN digital PH meter (DIGISUN electronics, 
Hyderabad, India) 
 
DETERMINATION OF ASH VALUE  
Two gms of the Siddhar Kulikai was weighed accurately in tarred  platinum or silica 
dish and incinerated at a temperature not exceeding 450˚c until free from carbon, then cooled 
and weighed. Calculate the percentage of ash with reference of the air dried drug. 
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WATER SOLUBLE ASH 
To the Gooch crucible containing the total ash, 25 ml of water was  added and boiled 
for 5 minutes. The insoluble matter was collected in a sintered glass crucible or on ash less 
filter paper. Washed with hot water and ignited in a crucible for 15 minutes at a temperature 
not exceeding 450˚c. Subtract the weight of the insoluble matter from the weight of the ash. 
The difference of the weight represents the water soluble ash. Calculate the percentage of 
water soluble ash with reference to the air dried drug. 
 
ACID INSOLUBLE ASH 
Ash was boiled for 5 minutes with 25 ml of 1:1 diluted. Hcl. The insoluble matter 
was collected in a Gooch crucible and placed on an ash  less filter paper, washed with water 
and then ignited. Finally cooled in a  desiccator and weighed. The percentage of insoluble 
ash was calculated with reference to the air dried drug. 
 
LOSS ON DRYING 
Five grams of the Siddhar Kulikai was heated in a hot oven at 105˚C  to a constant  
weight.  The percentage loss of weight was calculated as per  procedure. 
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CHEMICAL ANALYSIS 
 
 
               EXPERIMRNT 
 
OBSERVATION 
 
INFERENCE 
UNPURIFIED 
POORAM 
PURIFIED 
POORAM 
 
Appearance of the sample 
 
White in colour 
 
White in colour 
 
White in colour 
Solubility: 
a. A little of the sample is 
shaken well with distilled 
water 
b. A little of the sample is 
shaken well with Con.HCl 
and Con.H2SO4 
 
Insoluble 
 
 
Insoluble 
 
 
Absence of 
silicate 
 
Absence of 
silicate 
Action of heat: 
A small amount of the 
sample is taken in a dry test 
tube and heated gently at first 
and then strongly 
 
White fumes evolned 
 
Presence of 
carbonate and 
nitrate 
 
Presence of 
carbonate and 
nitrate 
Flame test: 
 The sample is mixed with 
Con.HCL in a watch glass 
and  introduced in luminous 
part of the Bunsen flame 
 
No colour flames 
appeared 
 
Absence of copper 
 
Absence of 
copper 
 
 
Ash Test: 
A filter paper is soaked into a 
mixture of sample and cobalt 
nitrate solution and 
introduced into the Bunsen 
flame and ignited 
 
No yellow colour 
flame 
 
Absence of 
sodium. 
 
Absence of 
sodium. 
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PREPARATION OF EXTRACT: 
 5g of sample was taken in a 250 ml of clean beaker and 50 ml of distilled water was 
added to it. Then it was boiled well for about 10 min. Then it is allowed to cool and filtered in a 
100 ml volumetric flask and made up to 100 ml with distilled water. This preparation is used for 
the qualitative analysis of acidic and basic radicals. 
TEST FOR BASIC RADICALS 
 
          PROCEDURE 
 
   OBSERVATION 
 
 UNPURIFIED 
     POORAM 
       
PURIFIED 
POORAM 
 
Test for Potassium: 
 A pinch of sample is 
treated with 2ml of sodium 
nitrate solution and then 
treated with 2ml of cobalt 
nitrate in 30% of glacial 
acetic acid. 
 
No formation of  
yellow colour 
precipitate  
 
Absence  
 of Potassium 
 
Absence of 
Potassium 
 
Test for Calcium: 
2 ml of extract is taken in a 
clean test tube. To this add 
2 ml of 4% ammonium 
oxide solution.   
 
No formation of white 
colour precipitate  
Absence of 
Calcium 
 
 
 
 
Absence of 
Calcium 
 
 
 
 
 
Test For Magnesium: 
To 2ml of extract, Sodium 
hydroxide solution is added 
in drops. 
 
  
 Formation of  white  
  colour precipitate 
 
 
Absence  of 
    Magnesium 
 
 
Absence  of 
   Magnesium 
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Test For Ammonium: 
To 2ml of extract few ml of 
Nessler's reagent and excess 
of sodium hydroxide 
solution are added. 
 
No appearance of 
Brown colour 
 
 
Absence of 
Ammonium 
 
Absence of 
Ammonium 
 
Test For Sodium: 
2 pinches of the sample is 
made into paste by using 
Hcl and introduced into the 
blue flame of Bunsen 
burner. 
 
No Characteristic 
changes 
 
 
Absence of 
Sodium 
 
Absence of 
Sodium 
 
Test for Iron (Ferrous):    
The extract is treated with 
Conc. HNO3 and 
ammonium thiocynate. 
 
Appearance of Blood 
red colour 
 
Presence of       
  Ferrous iron 
 
Presence of 
Ferrous iron 
 
Test For Zinc: 
To 2m1 of the extract 
sodium hydroxide solution 
is added in drops.  
  
No Formation of 
White colour 
precipitate 
 
Absence  of 
Zinc 
 
Absence  of 
Zinc 
 
Test For Aluminium: 
To the 2m1of the extract 
sodium hydroxide is added 
in drops. 
 
No Characteristic 
changes 
 
 
Absence  of 
Aluminium 
 
 
Absence  of 
Aluminium 
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Test For Lead: 
2 ml of  extract is added 
with 2ml of  potassium 
iodide solution. 
 
 
No Formation of 
yellow colour 
precipitate 
 
 
Absence  of 
Lead 
 
 
Absence  of 
Lead 
 
Test for Copper: 
a. One pinch of substance is 
made into paste with con. 
Hcl in a watch glass and 
introduced into the  
non-luminous part of the 
flame. 
b. 2 ml of extract is added 
with excess of ammonia 
solution. 
 
 
No Formation of Blue 
colour Precipitate. 
 
 
 
No Formation of  
Blue colour 
Precipitate 
 
 
Absence   
of Copper 
 
 
 
Absence   
of Copper 
 
 
 
Test For Mercury: 
2m1 of the extract is treated 
with 2ml of sodium 
hydroxide 
solution. 
 
  
Formation of Yellow 
precipitate 
 
 
Presence   
of Mercury 
 
 
Presence   
of Mercury 
 
Test for Arsenic:               
2m1 of the extract is treated 
with 2ml of sodium 
hydroxide solution. 
 
 
No Formation of 
Brownish red 
precipitate 
 
 
      Absence   
of Arsenic 
 
 
Absence   
of Arsenic 
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TEST FOR ACID RADICALS 
      
 
  
  
 
PROCEDURE 
 
OBSERVATION 
 
UNPURIFIED 
POORAM 
       
PURIFIED 
POORAM 
Test for Sulphate:                   
2 ml of the extract is added to 
5 % barium chloride solution. 
 
No formation of 
white precipitate 
 
Absence   
of Sulphate 
 
Absence   
of Sulphate 
Test for Chloride:               
The extract is treated with 
Silver nitrate solution. 
 
No Formation of 
White precipitate 
 
 Absence   
of Chloride 
 
Absence   
of Chloride 
Test for Phosphate :           
The extract is treated with 
ammonium molybdate and 
conc. HNO3. 
 
 Formation of 
Yellow precipitate 
 
Presence   
of Phosphate 
 
Presence   
of Phosphate 
Test for Carbonate :           
The substance is treated with 
Conc. HCl. 
 
No Formation of 
Effervescence 
 Absence of 
Carbonate 
Absence of 
Carbonate 
Test for fluoride & oxalate: 
2ml of extract is added with 
2ml of dil.acetic acid  and 2ml 
calcium chloride solution and 
heated. 
 
 
No Formation of 
cloudy appearance 
 
 
Absence of  
Fluoride & Oxalate 
 
 
Absence of 
Fluoride & Oxalate 
Test For Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated H2SO4 and 
viewed the test tube vertically 
down. 
 
No Characteristic 
changes 
 
Absence of Nitrate 
 
Absence of Nitrate 
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OTHER CONSTITUENTS 
 
PROCEDURE 
 
OBSERVATION 
                 
INFERENCE 
 
UNPURIFIED 
POORAM 
      
PURIFIED 
POORAM 
 
Test for Starch:                
The extract is added 
with weak iodine 
solution. 
 
 
Formation of blue 
colour 
 
 
Absence of Starch 
 
 
Absence of Starch 
Test for Reducing 
Sugar: 
5 ml of Benedict's 
qualitative solution is 
taken in a test tube and 
allowed to boil for 2 
min. 
 
Add 8 to 10 drops of 
extract and again boil 
it for 2min. The colour 
changes are noted. 
 
 
 
No Colour changes 
 
 
 
 
 
 
 
 
Absence of 
Reducing 
sugar 
 
 
 
 
 
 
 
 
Absence of Reducing 
sugar 
 
 
 
 
 
 
Test for  Alkaloids: 
a. 2ml of the extract is 
treated with 2ml of 
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potassium Iodide 
solution 
b. 2m1 of extract is 
treated with 2ml of 
picric acid 
 
c. 2m1 of the extract is 
treated with 2ml of 
phosphotungstic 
acid 
No Appearance of  
          Red colour 
 
 
No Appearance of 
Yellow colour 
 
 
No Appearance of  
white precipitate 
 
Absence of 
Alkaloids 
 
 
Absence of 
Alkaloids 
 
 
Absence of 
Alkaloids 
Absence of Alkaloids 
 
 
Absence of Alkaloids 
 
 
Absence of Alkaloids 
 
Test for amino acids:     
Dilute extract + 2ml of 
Ninhydrin’s solution. 
 
 
 
No Appearance of 
violet colour 
 
 
 
Absence of Amino 
acids 
 
 
 
Absence of Amino acids 
 
Test for Tannic acid :        
The extract is treated 
with Ferric chloride.  
 
 
 
No formation of Blue 
black precipitate 
 
 
 
Absence of Tannic 
acid 
 
 
 
Absence of Tannic acid 
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Test for type of 
Compound: 
2ml of the extract is 
treated with 2 ml of 
ferric chloride solution 
 
 
 
 
No Appearance of 
Green colour 
 
 
   
No Appearance of Red 
colour 
 
 
 
 
No Appearance of 
Violet colour 
 
 
 
No Appearance of Blue 
colour 
 
 
 
 
Absence of 
Oxyquinole, 
Epinephrine and 
Pyro catechol 
 
Absence of Anti -
pyrine, Aliphatic 
amino acids and 
Meconic acid 
 
Absence of 
Apomorphine 
Salicylate and 
Resorcinol 
 
Absence of 
Morphine, Phenol 
cresol and 
Hydroquinone 
 
 
 
Absence of Oxyquinole, 
Epinephrine and Pyro 
catechol 
 
Absence of Anti pyrine, 
Aliphatic amino acids, 
Meconic acid 
 
 
Absence of 
Apomorphine 
Salicylate and 
Resorcinol 
 
Absence of Morphine, 
Phenol 
Cresol, 
Hydroquinone 
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CHEMICAL ANALYSIS OF SIDDHAR KULIKAI 
 
               EXPERIMRNT 
 
OBSERVATION 
 
INFERENCE 
Siddhar kulkai 
 
Appearance of the sample 
 
Green  in colour 
 
Green in colour 
Solubility: 
a. A little of the sample is shaken 
well with distilled water 
b. A little of the sample is shaken 
well with con.HCl con.H2SO4 
 
Insoluble 
 
 
 
 
Absence of silicate 
 
 
 
Action of heat: 
A small amount of the sample is 
taken in a dry test tube and heated 
gently at first and the strongly 
 
White fumes 
 
Presence of carbonate 
and nitrate 
 
Flame test: 
The sample is mixed with Con.HCL 
in a watch glass and  introduced in 
luminous part of the Bunsen flame 
No colour flames appeared 
Absence of copper 
 
Ash Test: 
A filter paper is soaked into a 
mixture of sample and cobalt nitrate 
solution and introduced into the 
Bunsen flame and ignited 
 
No yellow colour flame 
 
 
 
 
 
Absence of sodium. 
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Preparation of extract: 
              5g of sample was taken in a 250 ml of clean beaker and 50 ml of distilled water 
was added to it. Then it was boiled well for about 10 min. Then it is allowed to cool and 
filtered in a 100 ml volumetric flask and made up to 100 ml with distilled water. This 
preparation is used for the qualitative analysis of acidic and basic radicals. 
 
               TEST FOR BASIC RADICALS 
 
 
PROCEDURE 
 
OBSERVATION 
 
INFERENCE 
Siddhar Kulikai 
 
Test for Potassium: 
 A pinch of sample is treated with 
2ml of sodium nitrate solution and 
then treated with 2ml of cobalt 
nitrate in 30% of glacial acetic acid. 
 
 
Formation of  Yellow colour 
precipitate 
 
Presence of 
Potassium 
 
Test for Calcium: 
2 ml of extract is taken in a clean test 
tube. To this add 2 ml of 4% 
ammonium oxide solution.   
 
Formation of white colour 
precipitate 
 
Presence of Calcium 
Test For Magnesium: 
To 2ml of extract, Sodium  
hydroxide solution is added in drops. 
 
Formation of White 
colour precipitate 
 
 Presence  of 
      Magnesium 
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`Test For Ammonium: 
To 2ml of extract few ml of Nessler's 
reagent and excess of sodium 
hydroxide solution are added. 
 
No appearance of Brown colour 
 
Absence of 
Ammonium 
Test For Sodium: 
2 pinches of the substance is 
made into paste by using Hcl and 
introduced into the blue flame of 
Bunsen burner. 
 
No Characteristic 
changes 
 
 
Absence of 
Sodium 
Test for Iron (Ferrous) :     
The extract is treated with Conc. 
HNO3 and ammonium thiocynate. 
 
Appearance of Blood red colour 
 
Presence of 
Ferrous iron 
Test For Zinc: 
To 2m1 of the extract sodium 
hydroxide solution is added indrops.  
 
No Formation of White colour 
precipitate 
 
Absence  of 
Zinc 
Test For Aluminium: 
To the 2m1of the extract sodium 
hydroxide is added in drops. 
 
No Characteristic 
changes 
 
Absence  of 
Aluminum 
Test For Lead: 
2 ml of extract is added with 2ml of  
potassium iodide solution. 
 
Formation of yellow colour 
precipitate 
 
Absence  of 
Lead 
Test for Copper: 
a. one pinch of substance is 
made into paste with con. Hcl in a 
watch glass and introduced into the 
non-luminous part of the flame. 
b. 2 ml of extract is added with 
excess of ammonia solution. 
 
No Formation of Blue colour 
Precipitate. 
 
 
Absence 
of Copper 
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Test For Mercury: 
2m1 of the extract is treated 
with 2ml of sodium hydroxide 
solution. 
 
 
 
Formation of Yellow precipitate 
 
 
 
 
Presence 
of Mercury 
 
Test for Arsenic:               
2m1 of the extract is treated 
with 2ml of sodium hydroxide 
solution. 
 
 
No Formation of Brownish red 
precipitate 
 
 
 
Absence 
of Arsenic 
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TEST FOR ACIDIC RADICALS 
     
  
 
PROCEDURE 
 
OBSERVATION 
 
SIDDHAR 
KULIKAI 
Test for Sulphate:                   
2 ml of the extract is added to 5 % 
barium chloride solution. 
 
No formation of white 
precipitate 
 
Absence  of Sulphate 
Test for Chloride :               
The extract is treated with Silver 
nitrate solution. 
 
No Formation of White 
precipitate 
 
Absence  of Chloride 
Test for Phosphate :           
The extract is treated with 
ammonium molybdate and conc. 
HNO3. 
 
Formation of 
Yellow precipitate 
 
Presence  of 
Phosphate 
Test for Carbonate :           
The substance is treated with Conc. 
HCl. 
 
No Formation of Effervescence 
Absence of 
Carbonate 
 
Test for fluoride & oxalate: 
2ml of extract is added with 2ml of 
dil.acetic acid and 2ml calcium 
chloride solution and heated.          
 
 
No Formation of cloudy 
appearance 
 
 
Absence of  Fluoride 
& Oxalate 
 
Test For Nitrate: 
1gm of the substance is heated with 
copper turnings and 
concentrated H2SO4 and 
viewed the test tube vertically down 
 
 
 
No Characteristic changes 
 
 
Absence of Nitrate 
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PROCEDURE 
 
OBSERVATION 
 
INFERENCE 
 
Test for Starch :                 
The extract is added with weak 
iodine solution.  
 
 
Formation of blue colour 
 
 
Presence of Starch 
 
Test for Reducing Sugar: 
5 ml of Benedict's qualitative 
solution is taken in a test tube 
and allowed to boil for 2 min. 
 
Add 8 to 10 drops of extract and 
again boil it for 2min. The colour 
changes are noted. 
 
 
No Colour changes 
 
 
 
Absence of Reducing 
sugar 
 
 
Test for  Alkaloids: 
a. 2ml of the extract is treated with 
2ml of potassium Iodide 
solution 
b. 2m1 of extract is treated with 2ml 
of picric acid 
c. 2m1 of the extract is treated with 
2ml of phosphotungstic acid 
 
 
        No Appearance of  
            Red colour  
Appearance of Yellow colour 
NO Appearance of  
white precipitate 
 
 
presence of Alkaloids 
 
Test for amino acids:     
 Dilute extract + 2ml of Ninhydrin’s 
solution. 
 
 
No Appearance of violet colour 
 
 
Absence of Amino 
acids 
 
Test for Tannic acid :         
The extract is treated with Ferric 
chloride.  
 
  
Formation of Blue black 
precipitate 
 
 
Presence  of Tannic 
acid 
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Test for type of Compound: 
2ml of the extract is treated with  
2 ml of ferric chloride solution 
 
 
 
No Appearance of Green colour 
 
 
   
 No Appearance of Red       
                  colour 
 
 
 
No Appearance of Violet colour 
 
 
 
No Appearance of Blue colour 
 
 
 
Absence of 
Oxyquinole, 
Epinephrine and  
Pyrocatechol 
Absence of Anti -
pyrine, Aliphatic 
amino acids and 
Meconic acid 
Absence of 
Apomorphine 
Salicylate and 
Resorcinol 
Absence of Morphine, 
Phenol 
cresol and 
Hydroquinone. 
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4.3. QUANTITATIVE ANALYSIS 
 
INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION           
SPECTROMETRY (ICP-OES)  
 
Introduction  
The elemental composition of a sample is often an important part of the 
information needed to assess its properties. Hence there is a need for sensitive scientific 
instrumentation like ICP-OES which plays a pivotal role in the determination of these 
elements. ICP-OES is widely employed for the estimation of metals and metalloids at 
trace, minor and major concentrations.  
 
Principle  
In this technique, the high temperature plasma source atomizes the sample and 
excites the atoms resulting in emission of photons .The atoms of each element in the 
sample emit specific wavelength of light. The emission spectrum from the plasma is 
dispersed by an optical spectrometer, so that intensities of the individual wavelength can 
64 be measured. The number of photons emitted is directly proportional to the 
concentration of the element. The photon may be detected either sequentially or 
simultaneously. Quantitative analysis is achieved by measuring the intensity of these 
specific wavelengths and after performing the calibration using known standards.  
 
Extraction of information  
Obtaining qualitative information, i.e., what elements are present in the sample, 
involves identifying the presence of emission at the wavelengths characteristic of the 
elements of interest. Obtaining quantitative information, i.e., how much of an element is 
in the sample, can be accomplished using plots of emission intensity versus concentration 
called calibration curves. Typical calibration graph is illustrated below 
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Sample preparation – Microwave Digestion Weigh 0.25g of test sample and transfer 
into a liner provided with the instrument.  Slowly add 9ml of Nitric acid or Sulphuric acid 
such that no piece of sample sticks on the slides. Mix thoroughly and allow reacting for 
few minutes.  Place the liner in the vessel jacket.  Close the screw cap hand-tight in 
clockwise direction. Seal the vessel and place in the rotor fixed in microwave. Set 
temperature to 180°C for 5 minutes; hold at 180°C for least 10 minutes.  Allow the 
vessels to cool down to a vessel interior temperature below 60°C and to a vessel surface 
temperature (IR) below 50°C before removing the rotor. The digested sample was made 
upto 100ml with millipore water.  If visible insoluble particles exist, solution could be 
filtered through whatmann filter   paper.  Transfer the digested solution into plastic 
containers and label them properly. 
   
 Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36  
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SCANNED ELECTRON MICROSCOPY (SEM)  
 
A SEM is essentially a high magnification microscope, which uses a focussed scanned 
electron beam to produce images of the sample, both top-down and, with the necessary 
sample preparation, cross-sections. The primary electron beam interacts with the sample 
in a number of key ways:-  
Ø Primary electrons generate low energy secondary electrons, which tend to 
emphasize the topographic nature of the specimen.  
Ø Primary electrons can be backscattered which produces images with a high 
degree of atomic number (Z) contrast.  
Ø Ionized atoms can relax by electron shell-to-shell transitions, which lead to 
either X-ray emission or Auger electron ejection. The X-rays emitted are 
characteristic of the elements in the top few μm of the sample.  
The SEM is carried out by using FEI-Quanta FEG 200-High Resolution Instrument. 
 Resolution: 1.2 nm gold particle separation on a carbon substrate  
Magnification: From a min of 12x to greater than 1, 00,000 X  
Application: To evaluate grain size, particle size distributions, material homogeneity and 
inter metallic distributions. 
Sample preparation: Sample preparation can be minimal or elaborate for SEM analysis, 
depending on the nature of the samples and the data required. Minimal preparation 
includes acquisition of a sample that will fit into the SEM chamber and some 
accommodation to prevent charge build-up on electrically insulating samples. Most 
electrically insulating samples are coated with a thin layer of conducting material, 
commonly carbon, gold, or some other metal or alloy. The choice of material for 
conductive coatings depends on the data to be acquired: carbon is most desirable if 
elemental analysis is a priority, while metal coatings are most effective for high resolution 
electron imaging applications. Alternatively, an electrically insulating sample can be 
examined without a conductive coating in an instrument capable of "low vacuum" 
operation. 
  Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36  
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FOURIER TRANSFORM - INFRA RED SPECTROSCOPY 
PERKIN ELMER – SPECTRUM ONE 
 
Introduction  
 
Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular structure. The spectral bands can be assigned to different vibrational modes of 
the molecule. The various functional groups present in the molecule can be assigned by a 
comparison of the spectra with characteristic functional group frequencies. As the 
positions of the bands are directly related to the strength of the chemical bond, a large 
number of investigations including intermolecular interactions, phase transitions and 
chemical kinetics can be carried out using this branch of spectroscopy.  
 
In FTIR spectroscopy, the resonance absorption is made possible by the change in 
dipole moment accompanying the vibrational transition. The Infrared spectrum originates 
from the vibrational motion of the molecule. The vibrational frequencies are a kind of 
fingerprint of the compounds. This property is used for characterization of 60 organic, 
inorganic and biological compounds. The band intensities are proportional to the 
concentration of the compound and hence qualitative estimations are possible. The IR 
spectroscopy is carried out by using Fourier transform technique.  
 
Principle  
Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction, electromagnetic radiation characteristic of 
the interacting system may be absorbed (or emitted). The experimental data consist of the 
nature (frequency of wave length) and the amount (intensity) of the characteristic 
radiation absorbed or emitted. These data are correlated with the molecular and electronic 
structure of the substance and with intra- and inter molecular interactions.  
FT-IR spectroscopy is used primarily for qualitative and quantitative analysis of organic 
compounds, and also for determining the chemical structure of inorganic materials. The 
region between 500-4000 wave numbers is referred to as the finger print region. 
Absorption bands in this region are generally due to intra molecular phenomena and are 
highly specific for each material. The specificity if these bands allow computerized data 
searches to be performed against reference libraries to identify a material.  
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Table of Characteristic IR Absorptions 
Frequency, cm–1 Bond Functional group 
3640–3610 (s, sh) O–H stretch, free hydroxyl alcohols, phenols 
3500–3200 (s,b) O–H stretch, H–bonded alcohols, phenols 
3400–3250 (m) N–H stretch primary, secondary amines, amides 
3300–2500 (m) O–H stretch carboxylic acids 
3330–3270 (n, s) –C(triple bond)C–H: C–
H stretch 
alkynes (terminal) 
3100–3000 (s) C–H stretch Aromatics 
3100–3000 (m) =C–H stretch Alkenes 
3000–2850 (m) C–H stretch Alkanes 
2830–2695 (m) H–C=O: C–H stretch Aldehydes 
2260–2210 (v) C(triple bond)N stretch Nitriles 
2260–2100 (w) –C(triple bond)C– stretch Alkynes 
1760–1665 (s C=O stretch carbonyls (general) 
1760–1690 (s) C=O stretch carboxylic acids 
1750–1735 (s) C=O stretch esters, saturated aliphatic 
1740–1720 (s) C=O stretch aldehydes, saturated aliphatic 
1730–1715 (s) C=O stretch alpha,beta–unsaturated esters 
1715 (s) C=O stretch ketones, saturated aliphatic 
1710–1665 (s) C=O stretch alpha,beta–unsaturated aldehydes, 
ketones 
1680–1640 (m) –C=C– stretch Alkenes 
1650–1580 (m) N–H bend primary amines 
1600–1585 (m) C–C stretch (in–ring) Aromatics 
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1550–1475 (s) N–O asymmetric stretch nitro compounds 
1500–1400 (m) C–C stretch (in–ring) Aromatics 
1470–1450 (m) C–H bend Alkanes 
1370–1350 (m) C–H rock Alkanes 
1360–1290 (m) N–O symmetric stretch nitro compounds 
1335–1250 (s) C–N stretch aromatic amines 
1320–1000 (s) C–O stretch alcohols, carboxylic acids, esters, 
ethers 
1300–1150 (m) C–H wag (–CH2X) alkyl halides 
1250–1020 (m) C–N stretch aliphatic amines 
1000–650 (s) =C–H bend Alkenes 
950–910 (m) O–H bend carboxylic acids 
910–665 (s, b) N–H wag primary, secondary amines 
900–675 (s) C–H "oop" Aromatics 
850–550 (m) C–Cl stretch alkyl halides 
725–720 (m) C–H rock Alkanes 
700–610 (b, s) –C(triple bond)C–H: C–
H bend 
Alkynes 
690–515 (m) C–Br stretch alkyl halides 
m=medium, w=weak, s=strong, n=narrow, b=broad, sh=sharp 
Sampling techniques: 
There are a variety of techniques for sample preparation depending on the 
physical form of the sample to be analyzed. 
Solid     : KBr or Nujol mull method. 
Liquid  : CsI / TlBr Cells 
Gas    :       Gas cells  
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36 
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KBr Method 
Ø The sample was grounded using- an agate mortar and pestle to give a very fine 
powder.  
Ø The finely powder sample was mixed with about 100mg dried KBr salt.  
Ø The mixture was then pressed under hydraulic press using a die to yield a 
transparent disc ( measure about 13mm diameter and 0.3mm in thickness), 
through which the beam of spectrometer passed. 
  Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36 
X-Ray Fluorescence (XRF) 
An X-ray fluorescence (XRF) spectrometer is an x-ray instrument used for 
routine, relatively non-destructive chemical analyses of rocks, minerals, sediments and 
fluids. It works on wavelength-dispersive spectroscopic principles that are similar to an 
electron microprobe (EPMA). However, an XRF cannot generally make analyses at the 
small spot sizes typical of EPMA work (2-5 microns), so it is typically used for bulk 
analyses of larger fractions of geological materials. The relative ease and low cost of 
sample preparation, and the stability and ease of use of x-ray spectrometers make this one 
of the most widely used methods for analysis of major and trace elements in rocks, 
minerals, and sediment. 
Fundamental Principles of X-Ray Fluorescence (XRF) 
The XRF method depends on fundamental principles that are common to several 
other instrumental methods involving interactions between electron beams and x-
rays with samples, including: X-ray spectroscopy (e.g., SEM - EDS), X-ray diffraction 
(XRD), and wavelength dispersive spectroscopy. Analysis of major and trace elements in 
geological materials by x-ray fluorescence is made possible by the behavior of atoms 
when they interact with radiation. When materials are excited with high-energy, short 
wavelength radiation (e.g., X-rays), they can become ionized. If the energy of the 
radiation is sufficient to dislodge a tightly-held inner electron, the atom becomes unstable 
and an outer electron replaces the missing inner electron. When this happens, energy is 
released due to the decreased binding energy of the inner electron orbital compared with 
an outer one. The emitted radiation is of lower energy than the primary incident X-rays 
and is termed fluorescent radiation. Because the energy of the emitted photon is 
characteristic of a transition between specific electron orbitals in a particular element, the 
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resulting fluorescent X-rays can be used to detect the abundances of elements that are 
present in the sample. 
 
Procedure 
The analysis of major and trace elements in geological materials by XRF is made 
possible by the behavior of atoms when they interact with X-radiation. An XRF 
spectrometer works because if a sample is illuminated by an intense X-ray beam, known 
as the incident beam, some of the energy is scattered, but some is also absorbed within the 
sample in a manner that depends on its chemistry. The incident X-ray beam is typically 
produced from a Rh target, although W, Mo, Cr and others can also be used, depending 
on the application.  
 
When this primary X-ray beam illuminates the sample, it is said to be excited. The 
excited sample in turn emits X-rays along a spectrum of wavelengths characteristic of the 
types of atoms present in the sample. How does this happen? The atoms in the sample 
absorb X-ray energy by ionizing, ejecting electrons from the lower (usually K and L) 
energy levels. The ejected electrons are replaced by electrons from an outer, higher 
energy orbital. When this happens, energy is released due to the decreased binding energy 
of the inner electron orbital compared with an outer one. This energy release is in the 
form of emission of characteristic X-rays indicating the type of atom present. If a sample 
has many elements present, as is typical for most minerals and rocks, the use of 
a Wavelength Dispersive Spectrometer much like that in an EPMA allows the separation 
of a complex emitted X-ray spectrum into characteristic wavelengths for each element 
present. Various types of detectors (gas flow proportional and scintillation) are used to 
measure the intensity of the emitted beam. The flow counter is commonly utilized for 
measuring long wavelength (>0.15 nm) X-rays that are typical of K spectra from elements 
lighter than Zn. The scintillation detector is commonly used to analyze shorter 
wavelengths in the X-ray spectrum (K spectra of element from Nb to I; L spectra of             
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Th and U). X-rays of intermediate wavelength (K spectra produced from Zn to Zr and L 
spectra from Ba and the rare earth elements) are generally measured by using both 
detectors in tandem. The intensity of the energy measured by these detectors is 
proportional to the abundance of the element in the sample. The exact value of this 
proportionality for each element is derived by comparison to mineral or rock standards 
whose composition is known from prior analyses by other techniques. 
 
X-Ray fluorescence is particularly well-suited for investigations that involve 
Ø bulk chemical analyses of major elements (Si, Ti, Al, Fe, Mn, Mg, Ca, Na, K, 
P) in rock and sediment 
Ø bulk chemical analyses of trace elements (in abundances >1 ppm; Ba, Ce, Co, 
Cr, Cu, Ga, La, Nb, Ni, Rb, Sc, Sr, Rh, U, V, Y, Zr, Zn) in rock and sediment - 
detection limits for trace elements are typically on the order of a few parts per 
million 
Ø X-ray fluorescence is limited to analysis of 
Ø relatively large samples, typically > 1 gram 
Ø materials that can be prepared in powder form and effectively homogenized 
Ø materials for which compositionally similar, well-characterized standards are 
available 
Ø materials containing high abundances of elements for which absorption and 
fluorescence effects are reasonably well understood 
In most cases for rocks, ores, sediments and minerals, the sample is ground to a fine 
powder. At this point it may be analyzed directly, especially in the case of trace element 
analyses. However, the very wide range in abundances of different elements, especially 
iron, and the wide range of sizes of grains in a powdered sample, makes the 
proportionality comparison to the standards particularly troublesome. For this reason, it is 
common practice to mix the powdered sample with a chemical flux and use a furnace or 
gas burner to melt the powdered sample. Melting creates a homogenous glass that can be 
analyzed and the abundances of the (now somewhat diluted) elements calculated. 
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Strengths 
X-Ray fluorescence is particularly well-suited for investigations that involve: 
Ø bulk chemical analyses of major elements (Si, Ti, Al, Fe, Mn, Mg, Ca, Na, K, P) 
in rock and sediment 
Ø bulk chemical analyses of trace elements (>1 ppm; Ba, Ce, Co, Cr, Cu, Ga, La, 
Nb, Ni, Rb, Sc, Sr, Rh, U, V, Y, Zr, Zn) in rock and sediment 
Done at sastra university, Tanjore. 
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4.4. TOXICOLOGICAL EVALUATION OF  SIDDHAR KULIKAI  
IN RODENTS 
Introduction: 
      Safety is a fundamental principle in the provision of traditional medicines and 
herbal products for health care and a critical component of quality control. OECD 
guidelines provide practical and technical guidance for monitoring the safety of 
traditional medicines within pharmacovigilance systems. The safety monitoring of 
traditional medicines is compared and contrasted with that of other medicines, currently 
undertaken in the context of the WHO International Drug Monitoring Programme. While 
there are regulatory and cultural differences in the preparation and use of different types 
of medicines, they are all equally important from a pharmacovigilance perspective. 
Scope of work: 
Assurance of safety, quality and efficacy of Indian System of Medicines (ISM) is 
the key issue that needs to be addressed while conducting toxicity studies. It is an 
essential step, which will strengthen the acceptance of Siddha medicines by scientific 
community. Information of toxicity and adverse effects of these formulations are lacking. 
Some of the formulations are proved to be effective in various animal studies and many 
more are yet to be tested.  
Hence, the present study was carried out to evaluate the Preclinical animal toxicity 
studies of SIDDHA KULIKAI in rodents.  
 
Plan of work: 
 
The following studies were carried out on SIDDHAR KULIKAI          
Ø Acute Oral toxicity – Acute Toxic Class Method - 423(OECD) 
Ø 28-Days Repeated Dose Oral Toxicity Study - 407(OECD) 
 
 
 
 
 
 
 
83 
 
ACUTE ORAL TOXICITY STUDY OF SIDDHAR KULIKAI 
( OECD GUIDELINE – 423 ) 
Introduction: 
1. The acute toxic class method is a stepwise procedure with the use of 3 animals of 
a single sex per step. 
2. Depending on the mortality and/or the moribund status of the animals, on average 
2-4 steps may be necessary to allow judgement on the acute toxicity of the test 
substance.  
3. This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
4. The acute toxic class method is based on biometric evaluations with fixed doses, 
adequately separated to enable a substance to be ranked for classification purposes 
and hazard assessment.  
5. In principle, the method is not intended to allow the calculation of a precise LD50, 
but does allow for the determination of defined exposure ranges where lethality is 
expected since death of a proportion of the animals is still the major endpoint of 
this test.  
6. The method allows for the determination of an LD50 value only when at least two 
doses result in mortality higher than 0% and lower than 100%.  
7. The use of a selection of pre-defined doses, regardless of test substance, with 
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability.  
 
Principle of the Test:  
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. Absence 
or presence of compound-related mortality of the animals dosed at one step will 
determine the next step, i.e.; 
 − no further testing is needed, 
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 − dosing of three additional animals, with the same dose  
− dosing of three additional animals at the next higher or the next lower dose 
level. The method will enable a judgment with respect to classifying the test substance to 
one of a series of toxicity classes.  
 
METHODOLOGY:  
 
Selection of Animal Species  
 The preferred rodent species is the wistar albino rat, although other rodent species 
may be used. Healthy young adult animals are commonly used laboratory strains should 
be employed. Females should be nulliparous and non-pregnant. Each animal, at the 
commencement of its dosing, should be between 6 to 8 weeks old and the weight (150-
200gm) should fall in an interval within±20 % of the mean weight of any previously 
dosed animals.  
 
Housing and Feeding Conditions 
 The temperature in the experimental animal room should be 22ºC + 3ºC.  
Although the relative humidity should be at least 30% and preferably not exceed 70% 
other than during room cleaning the aim should be 50-60%. Lighting should be artificial, 
the sequence being 12 hours light, 12 hours dark. For feeding, conventional laboratory 
diets may be used with an unlimited supply of drinking water. Animals may be group-
caged by dose, but the number of animals per cage must not interfere with clear 
observations of each animal.  
 
Test Substance and Vehicle  
 The Siddhar kulikai is in Green colour. The test substance is freely insoluble in 
water. In order to ensure the uniformity in drug distribution in the medium the suspension 
was made with 10% aqueous Tween 80 solution and it was found suitable for dose 
accuracy.  
 
Justification for Choice of Vehicle: 
The vehicle selected as per the standard guideline which is pharmacologically 
inert and easy to employ for new drug development and evaluation technique.  
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 Test Animals and Test Conditions:  
 Sexually mature Female Wistar albino rats (150-200gm) were obtained from the 
Sri Ragavendra Enterprises, Bangalore. All the animals were kept under standard 
environmental condition (22±3°C).  The animals had free access to water and standard 
pellet diet (Sai meera foods, Bangalore). Rats were deprived of food but not water (16-18 
h) prior to administration of the Siddhar kulikai. The principles of laboratory animal care 
were followed and the Institutional Animal Ethical Committee approved the use of the 
animals and the study design. (IAEC PROTOCOL NO: 1248/AC/09/CPCSEA/4-
36/2011). 
 
Administration of Doses:  
 Siddhar kulikai suspended in 10% aqueous Tween 80 with vigourous mixing and 
was administered to the groups of wistar albino rats in a single oral dose by gavage using 
a feeding needle. The control group received an equal volume of the vehicle. Animals 
were fasted 12 hours prior to dosing. Following the period of fasting, the animals were 
weighed and then the test substance was administered. Three Female animals are used for 
each group. The dose level of 5, 50, 300 and 2000 mg/kg body weight was administered 
stepwise. After the substance has been administered, food was withheld for a further 3-4 
hours. The principle of laboratory animal care was followed. Observations were made and 
recorded systematically and continuously observed as per the guideline after substance 
administration. The visual observations included skin changes, mobility, aggressively, 
sensitivity to sound and pain, as well as respiratory movements. Finally, the number of 
survivors was noted after 24 h and these animals were then monitered for a further 14 
days and observations made daily. The toxicological effect was assessed on the basis of 
mortality. 
 
Species and strain         : Wistar Albino rat 
Sex                                      : Female 
Age/Weight             :  6-8 weeks/150-200 gm 
Accimatization  :  7days prior to dosing 
Test guideline                      :  OECD guideline - 423 
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Groups/treatment              :  Grouped by randomization                 
Duration of exposure           :    Single dose 
Study duration                     :    14 days              
Number of animals             :    3 Female/group,  
Route of administration      :    Oral    
 
Groups No of Rat 
Group I  Vehicle control  3  female 
Group II  Test drug – 5mg/kg b.wt 3  female 
Group III   Test drug – 50 mg/kg b.wt 3  female 
Group IV Test drug – 300 mg/kg b.wt 3  female 
Group V  Test drug – 2000 mg/kg b.wt 3  female 
 
Behaviour: 
 The animals will be observed closely for behaviour in the first four hours which  
includes abnormal gait, aggressiveness, exophthalmos , ptosis , akinesia , catalepsy, 
convolusion, excitation, head twitches, lacrimation, loss of corneal reflex, loss of traction, 
piloerection  reactivity of touch, salivation, scratching, sedation, chewing,  head 
movements, sniffing, straub, tremor and writhes, diarrhea, leathery, sleep and coma.  
 
Observations:  
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 
4 hours, and daily thereafter, for a total of 14 days, except where they need to be removed 
from the study and humanely killed for animal welfare reasons or are found dead. It 
should be determined by the toxic reactions, time of onset and length of recovery period, 
and may thus be extended when considered necessary. The times at which signs of 
toxicity appear and disappear are important, especially if there is a tendency for toxic 
signs to be delayed. All observations are systematically recorded with individual records 
being maintained for each animal.  
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Observations include changes in skin and fur, eyes and mucous membranes, and 
also respiratory, circulatory, autonomic and central nervous systems, and somatomotor 
activity and behavior pattern. Attention was directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. The principles and criteria 
summarized in the Humane Endpoints Guidance Document taken into consideration. 
Animals found in a moribund condition and animals showing severe pain or enduring 
signs of severe distress was humanly killed. When animals are killed for human reasons 
or found dead, the time of death should was recorded. 
 
Body Weight:  
 Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 2, 7 and 14 of the study. Weight 
changes were calculated and recorded. At the end of the test, surviving animals were 
weighed and humanly killed.  
Mortality: 
 Animals will be observed for mortality throughout the entire period. 
Gross necropsy: 
 At the end of 14th day animals will be sacrificed for gross necropsy. It includes 
examination of the external surface of the body, all orifices, and organs like Brain, Lungs, 
Heart, Spleen, Liver, Kidneys, Adrenals and Sex Organs of all animals.If there will any 
occurrence of mortality during the trial period, the vital organs will be subjected to 
histopathological study 
Results: 
 All data were summarized in tabular form, (Table-1) showing for each test group 
the number of animals used, the number of animals displaying signs of toxicity, the 
number of animals found dead during the test and description of toxic symptoms. 
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28-DAYS REPEATED DOSE ORAL TOXICITY STUDY OF 
 SIDDHAR KULIKAI ( OECD GUIDELINE -407 ) 
 
Test Substance  : Siddhar Kulikai 
Animal Source  : King Institute of Preventive Medicine, Guindy, Chennai.   
Animals   : Wister Albino Rats (Male -3, and Female-3) 
Age    : 6-8 weeks 
Body Weight on Day 0 : 150-200gm. 
Acclimatization  : Seven days prior to dosing. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number and individual marking     
by using Picric acid. 
 
Diet    : Pellet feed supplied by Sai meera foods Pvt Ltd,        
    Bangalore 
Water    : Aqua guard portable water in polypropylene bottles. 
 
Housing & Environment : The animals were housed in Polypropylene cages 
provided with bedding of husk. 
 
Housing temperature :  between 22ºC + 3ºC.    
Relative humidity  :  between 30% and 70%, 
Air changes    : 10 to 15 per hour and  
Dark and light cycle   : 12  : 12 hours. 
Duration of the study : 28 Days 
Justification for Dose Selection: 
          As per OECD guideline  three dose levels were  selected for the study they are low 
dose(x),mid dose dose(5x),high dose(10x).X is calculated by multiplying the therapeutic 
dose(84 mg) and the body surface area of the rat(0.018). i.e X dose is 3.024 
mg/animal,5X dose is 15.12 mg/animal,10X dose is 30.24 mg/animal.  
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Preparation and Administration of Dose: 
 Siddhar kulikai was suspended in 10% aqueous Tween 80 in distilled water to 
obtain concentrations of 200mg/ml. It was administered to animals at the dose levels of x, 
5x, 10x. The test substance suspensions were freshly prepared every two days once for 28 
days. The control animals were administered vehicle only. The drug was Administered 
orally  by using oral gavage  once daily for 28 consecutive days. 
 
METHODOLOGY 
 
Randomization, Numbering and Grouping of Animals: 
Wistar Albino Rats (Male -3, and Female-3) were in each group randomly divided 
into four groups for dosing up to 28 days. Animals were allowed acclimatization period 
of 7 days to laboratory conditions prior to the initiation of treatment. Each animal was 
marked with picric acid. The females were nulliporous and non-pregnant. 
 
OBSERVATIONS: 
 
Experimental animals were kept under observation throughout the course of 
study for the following: 
 
 
Ø Body Weight: Weight of each rat was recorded on day 0, at weekly intervals 
throughout the course of study and at termination to calculate relative organ 
weights. From the data, group mean body weights and percent body weight gain 
were calculated. (Table-2) 
Ø Food and water Consumption: The quantity of food consumed by groups 
consisting of six animals of for different doses was recorded at weekly interval. 
Food consumed per animal was calculated for control and the treated dose groups. 
(Table-3&4) 
Ø Clinical signs: All animals were observed daily for clinical signs. The time of 
onset, intensity and duration of these symptoms, if any, were recorded. 
Ø Mortality: All animals were observed twice daily for mortality during entire 
course of study. 
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Ø Functional Observations: At the end of the study exposure, ‘sensory reactivity’ 
to graded stimuli of different types (auditory, visual and proprioceptive stimuli), 
‘motor reactivity’ and ‘grip strength’ were assessed. 
Ø Laboratory Investigations: Following laboratory investigations were carried out 
on day 29 in animals’fasted over-night. Blood samples were collected from orbital 
sinus using sodium heparin (200IU/ml) for Bio chemistry and potassium EDTA 
(1.5 mg/ml) for Haematology as anticoagulant. Blood samples were centrifuged at 
3000 r.p.m. for 10 minutes. 
Ø Haematological Investigations: Haematological parameters were determined 
using Haematology analyzer. (Table-5) 
Ø Biochemical Investigations: Biochemical parameters were determined using 
auto-analyzer.(Table-6, 7 & 8) 
Ø Necropsy: All the animals were sacrificed by excessive anaesthesia on day 29. 
Necropsy of all animals was carried out. 
Ø Histopathology:  
         Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group 
than the low, then the mid dose group will also be examined. Organs will be collected 
from all animals and preserved in 10% buffered neutral formalin for 24 h and washed 
in running water for 24 h.  The organ  sliced 5 or 6µm sections and were dehydrated 
in an auto technicon and then cleared in benzene to remove absolute alcohol. 
Embedding was done by passing the cleared samples through three cups containing 
molten paraffin at 50°C and then in a cubical block of paraffin made by the “L” 
moulds. It was followed by microtome and the slides were stained with 
Haematoxylin-eosin. 
 
Ø Statistical analysis:  
o Findings such as clinical signs of intoxication, body weight changes, food 
consumption, haematology and blood chemistry were subjected to One-
way ANOVA followed by dunnet’t’ test using a computer software 
programme -INSTAT-V3 version. 
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RESULTS OF QUALITATIVE ANALYSIS 
RESULTS OF PHYSICO CHEMICAL ANALYSIS 
Colour: Green 
Nature:         Solid  
 
Physicochemical Properties of  Siddhar Kulikai. 
S No. Parameters  Values obtained 
(%w/w) 
1 Total ash value  8.77 
2 Acid insoluble ash  0.83 
3 Water soluble ash  6.7 
4 Moisture content  9.75 
5 Foreign organic matter  7.8 
6 Crude fibre content  25.0 
7 Alcohol soluble extractive  6.4 
8 Water soluble extractive  10.33 
9. pH 7.5-7.7 
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Preliminary Phytochemical Analysis of Different Extracts of Siddhar Kuligai: 
 
 
S.no 
 
Phytoconstituents 
 
Aqueous 
 
1 Alkaloids + 
2 Flavonoids + 
3 Saponins + 
4 Glycosides + 
5 Carbohydrates + 
6 Amino acids   + 
7 Triterpenoids + 
(+ )Present,   (−)  Absent. 
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RESULTS OF CHEMICAL ANALYSIS 
 
The Qualitative analysis of UNPURIFIED POORAM indicates the presence of, 
Ø Carbonate and nitrate 
Ø Ferrous Iron 
Ø Mercury 
Ø Phosphate. 
 
The Qualitative analysis of  PURIFIED POORAM indicates the presence of, 
Ø Carbonate and nitrate 
Ø Ferrous Iron 
Ø Mercury 
Ø Phosphate. 
 
The Qualitative analysis of  SIDDHAR KULIKAI indicates the presence of, 
Ø Carbonate and nitrate 
Ø Potassium 
Ø Calcium 
Ø Magnesium 
Ø Ferrous Iron 
Ø Mercury 
Ø Phosphate 
Ø Starch 
Ø Alkaloids 
Ø Tannic acid. 
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RESULTS OF QUANTITATIVE ANALYSIS 
Result of HRSEM Analysis 
 
 
 
 
Size  : 1.5 – 3micron 
Shape  : Spherical 
Distribution :           Evenly distributed 
Surface : smooth 
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RESULT OF  FTIR ANALYSIS 
 
 
 
Functional 
group (Bond) 
Type of Vibration  Functional group Characteristic Absorptions (cm-1) 
Standard  frequency 
CH (Strong) Alkynes                   582,682     
=C-H&=CH2 (Strong) Alkenes                   867,909 
N-H 
(1˚,2˚amines) 
(Medium) Amines 1013,1240,1278,1518(m),3389(wk) 
α- CH3 Bending (Strong)   Aldehyde ,Ketones 1346,1438,2929(m) 
OH,C=O (Strong)  Carboxylic acids &      
       Derivatives 
1629,2854 
OH (Strong)               
  Alcohol&Phenols 
3562 
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RESULT OF XRF ANALYSIS 
Formula Z Concentration Status Line 1 Net int. Calc. concentration Stat. error LLD 
Analyzed 
layer 
Hg 80 72.73% XRF 0 Hg LA1-HR-Tr 2776 72.73 0.11% 972.9 PPM 17.0 um 
O 8 12.67% XRF 0 O  KA1-HR 1.064 11 15.40% 1.47% 0.180 um 
S 16 7.77% XRF 0 S  KA1-HR-Tr 206.6 7.769 0.40% 118.1 PPM 1.73 um 
Cl 17 4.27% XRF 0 Cl KA1-HR-Tr 38.63 4.27 0.92% 282.9 PPM 0.89 um 
As 33 1.07% XRF 0 As KA1-HR-Tr 142.6 1.068 0.50% 146.1 PPM 19.6 um 
Si 14 0.24% XRF 0 Si KA1-HR-Tr 3.236 0.238 3.80% 219.8 PPM 1.13 um 
K 19 0.20% XRF 0 K  KA1-HR-Tr 1.846 0.201 4.56% 163.0 PPM 1.11 um 
Tl 81 0.18% XRF 0 Tl LA1-HR-Tr 6.995 0.18 9.95% 332.8 PPM 18.2 um 
Mg 12 0.16% XRF 0 Mg KA1-HR-Tr 3.472 0.16 10.60% 513.4 PPM 0.58 um 
Mn 25 0.16% XRF 0 Mn KA1-HR-Tr 4.688 0.16 3.23% 132.2 PPM 4.4 um 
Fe 26 0.14% XRF 0 Fe KA1-HR-Tr 5.886 0.142 2.91% 110.2 PPM 5.4 um 
Ca 20 0.09% XRF 0 Ca KA1-HR-Tr 0.9187 0.093 7.20% 186.3 PPM 1.38 um 
Pb 82 0.09% XRF 0 Pb LB1-HR-Tr 2.705 0.088 22.80% 427.2 PPM 13.0 um 
Al 13 0.08% XRF 0 Al KA1-HR-Tr 0.9969 0.082 6.62% 122.8 PPM 0.80 um 
Se 34 0.06% XRF 0 Se KA1-HR-Tr 5.608 0.064 12.40% 184.7 PPM 23.1 um 
Pt 78 0.05% XRF 0 Pt LA1-HR-Tr 1.954 0.049 11.80% 235.8 PPM 14.7 um 
V 23 0.04% XRF 0 V  KA1-HR-Tr 0.6332 0.036 12.10% 154.2 PPM 2.84 um 
 RESULT OF  ICP-OES ANALYSIS 
(Inductively Coupled Plasma Optical Emission   Spectrometry) 
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96 
 
RESULTS: 
 
Table 1: Dose finding experiment and its behavioral Signs of acute oral Toxicity 
 
No Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. 5 - - - - - - - - - - - - - - - - - - 
 ↑ 
0 
2 50 - - - - - - - - - - - - - - - - + - 
 ↑ 
0 
3 300 - - - + - - - - - - - - - - - - - - 
 ↑ 
 0 
4 2000 + - - + - - - - - - - - - - - - + - ↑ 0 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. 
Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. 
Exophthalmos 17. Diarrhoea 18. Writhing 19. Body weight 20. Number of deaths.         
(+)Positive response.  (-) Negative response.  (↑) Increased.  
 
  Table 2. Body wt (g) of wistar albino rats exposed to Siddhar kulikai for 28days. 
 Days 
1 7 14 21 28 
Control 154.36 ± 6.20 156.35 ± 5.08 155.31 ± 6.18 158.11 ± 8.10 159.40 ± 8.50* 
Low dose 151.00 ± 8.18 153.12 ± 7.14 154.65 ± 8.84 154.74 ± 11.55 156 ± 11.10*  
Mid dose 153.09 ± 5.91 153.69 ± 9.41 154 ± 10.11 154.90 ± 11.10 155.80 ± 12.11* 
High dose 153.80 ± 11.11 154 ± 10.11 156 ± 14.65 157.00 ± 15.08 159.08 ± 12.12* 
 
         Values are mean of 6 animals  ±  S.D. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
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Table 3. Food (g/day) intake of albino rats exposed to Siddhar kulikai for 28days. 
 Days 
1 7 14 21 28 
Control 37.98 ± 2.19 35.50 ± 2.77 38.97 ± 2.80 37.10 ± 3.01 39.01 ± 2.89 
Low dose 36.33 ± 2.35 37.80 ± 3.01 36.2 ± 1.90 37.37 ± 3.80 39.80 ± 3.40 
Mid dose 40.65 ± 4.01 39.80 ± 2.90 41.08 ± 2.56 42.80 ± 2.80 41.80 ± 4.80 
High dose 43.3 ± 2.00 41.20 ± 3.80 42.70 ± 2.89 43.08 ± 4.09 40.44 ± 1.80 
Values are mean of 6 animals  ±  S.D. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
 
Table 4. Water (ml/day) intake of male and female albino rats exposed to  
Siddhar kulikai for 28days. 
 
 
Days 
1 7 14 21 28 
Control 45.18 ± 3.00 43.15 ± 8.32 42.20 ± 1.25 43.12 ± 1.80 41.08 ± 3.04 
Low dose 53.83 ± 2.81** 52.80 ± 3.02** 50.18 ± 1.86** 49.01 ± 3.20** 45.30 ± 2.10** 
Mid dose 48.01 ± 2.08 45.90 ± 3.07 43.37 ± 3.19 45.80 ± 2.28** 43.80 ± 3.09 
High dose 48.80 ± 2.88 47.28 ± 1.80 48.60 ± 1.08 45.01 ± 2.18** 48.01 ± 2.53** 
 
Values are mean of 6 animals  ±  S.D. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
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Table 5. Hematological parameters after 28 days treatment with   
Siddhar kulikai in rats. 
Parameter Control Low dose Mid dose High dose 
Red blood cell 
(mm3) 
8.41 ± 0.17 7.01 ± 0.08** 7.20 ± 0.27** 7.40 ± 0.11** 
HB (%) 16.20 ± 0.31 16.00 ± 0.26 16.10 ± 0.88 16.16 ± 0.98 
Leukocyte 
(x106/mL) 
10129 ± 116.43 10144 ± 311.04** 12190 ± 546.75** 11475 ± 368.30** 
Platelets/ul 1349 ± 29.66 1298 ± 103.34** 1295 ± 101.34 1189 ± 27.33** 
MCV (gl) 58.78 ± 4.36 55.38 ± 3.68 54.68 ± 2.11* 55.36 ± 4.60* 
DLC (%) 
N 4.66 ± 0.72 5.20 ± 1.56 4.50 ± 0.53 5.00 ± 2.16 
L 91.86 ± 3.54 92.80 ± 3.46 90.12 ± 3.18 91.80 ± 3.03 
M 2.0 ± 0.38 2.1 ± 0.48 2.07 ± 1.09 2.36 ± 0.32 
E 1.12 ± 0.22          2.0 ±0.34** 2.0 ± 0.20** 1.64 ± 0.34* 
B 0 0 0 0 
ESR(mm) 2 ± 00 2.4 ± 00 2.1 ± 00 2.2 ± 00 
PCV 48.20 ± 1.88 43.89 ± 2.10 45.38 ± 1.66 44.10 ± 2.14 
MCH pg 18.18 ± 0.25 18.25 ± 1.45 18.39 ± 0.47 18.40 ± 0.10 
MCHC g/dl 30.56 ± 0.88 31.10 ± 0.41 30.44 ± 1.22 30.05 ± 0.44 
Values are mean of 6 animals  ±  S.D. (Dunnett's test). *P<0.05; **P<0.01. N=6. 
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Table 6. Effect of treatment with Siddhar kulikai biochemical parameters. 
LFT 
Dose (mg/kg) Control Low Dose Mid Dose High Dose 
Total Bilirubin 
(mg/dL) 
0.506 ± 0.01 0.513 ± 0.04 0.516 ± 0.05 0.514 ± 0.01 
Bilirubin direct 
(mg/dL) 
0.1 ± 0.02 0.1 ± 0.04 0.1 ± 0.03 0.1 ± 0.04 
Bilirubin 
indirect(mg/dL) 
0.1 ± 00 0.1 ± 00 0.1 ± 00 0.1 ± 00 
ALP (U/L) 381.41 ± 
10.12 
373.20 ± 11.33 385.32 ± 10.20 291.1 ± 11.33** 
SGOT (U/L) 167.13 ± 6.22 158.67 ± 5.57 165.36 ± 4.77 153.31 ± 5.54* 
SGPT(U/L) 45.4 ± 1.23 44.3 ± 3.12 44.01 ± 2.32 45.66 ± 4.04 
Total Protein(g/dl) 10.01 ± 1.10 8.70 ± 0.20 8.02 ± 0.17 8.90 ± 0.08 
Albumin(g/dl) 3.12 ± 0.20 2.98 ± 0.20 3.24 ± 0.23 2.96 ± 0.10 
Globulin(g/dl) 5.82 ± 0.08 5.68 ± 0.22 5.58 ± 0.20 4.82 ± 0.28** 
A/G Ratio(g/dl) 0.54 ± 0.04 0.51 ± 0.10 0.52 ± 0.09 0.61 ± 0.08** 
GGT(U/L) 7.4 ± 0 7.2 ± 0 7.8 ± 0 8 ± 0 
Values are mean of 6 animals  ±  S.D. (Dunnett's test). *P<0.05; **P<0.01. vs. control 
groupN=6                                                          
 
Table-7 RFT 
Dose (mg/kg) Control Low Dose Mid Dose High Dose 
Urea(mg/dL) 57.89 ± 1.55 60.90 ± 3.25 60.10 ± 1.98 62.31 ± 1.44* 
Creatinine (mg/dL) 0.78 ± 0.06 0.75 ± 0.04 0.79 ± 0.07 0.76 ± 0.06 
Uric acid (mg/dL) 3.4 ± 0.08 3.4 ± 0.20 3.6 ± 0.18 3.63 ± 0.10 
Na m.mol 138.10 ± 7.10 140.8 ± 4.18 143.11 ± 3.90 141.25 ± 4.08 
K m.mol 20.60 ± 2.78 20.48 ± 1.50 20.7 ± 1.10 19.15 ± 2.10 
Cl m.mol 99.80 ± 3.00 100.80 ± 6.06 102.06 ± 8.85 101.46 ± 6.26 
Values are mean of 6 animals  ±  S.D. (Dunnett's test). *P<0.05; **P<0.01. vs. control 
group N=6. 
 
 
100 
 
Table-8. Lipid Profile 
Dose (mg/kg) Control Low Dose Mid Dose High Dose 
Total cholestrol(mg/dL) 42.88 ± 2.68 41.5 ± 2.69 43.01 ± 3.03 45.80 ± 3.09* 
HDL(mg/dL) 12.16 ± 1.45 12.28 ± 
1.36** 
12.25 ± 1.28** 13.00 ± 1.80** 
LDL(mg/dL) 31.68 ± 2.68 35.16 ± 3.13 36.50 ± 3.80 37.30 ± 2.80 
VLDL(mg/dl) 16.09 ± 3.01 16.06 ± 2.31 16.15 ± 2.47 16.11 ± 2.36 
Triglycerides (mg/dl) 83.05 ± 3.48 82.31 ± 3.01 90.15 ± 5.00** 90.38 ± 2.98** 
TC/HDL ratio (g/dl) 3.40 ± 0.01 3.39 ± 0.16 3.56 ± 0.17 3.53 ± 0.26 
Blood glucose(mg/dl) 102.16 ± 8.26 112.2 ± 5.36 113.83 ± 6.69 120.6 ± 2.36** 
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RESULTS  OF TOXICITY STUDY 
ACUTE ORAL TOXICITY STUDY OF SIDDHAR KULIKAI    ( OECD 
GUIDELINE – 423 ) 
Ø In  Acute oral  toxicity study female wistar albino ,rats are treated with the dose 
level of 5mg/kg bw, 50mg/kg bw, 300mg/kg bw,  2000mg/kg bw. 
Ø Mortality was not observed up to dose level of 2000mg/kg bw.   
 
28-DAYS REPEATED DOSE ORAL TOXICITY STUDY OF  SIDDHAR 
KULIKAI  ( OECD GUIDELINE -407 ) 
 
Clinical signs: 
 Clinical signs was not observed during the dosing period of 28 days. 
Mortality:  
 All animals from control and all the treated dose groups survived throughout the 
dosing period of 28 days.  
Body weight:  
 Results of body weight of animals from control and different dose groups 
exhibited comparable body weight gain throughout the dosing period of 28 days (Table-2) 
Food consumption:  
 During dosing period, the quantity of food consumed by animals from different 
dose groups was found to be comparable and normal with that by control animals. 
water consumption: 
 During dosing period, the quantity of water consumed by animals from different 
dose groups was found to be comparable and normal with that by control animals. 
Haematological investigations:  
The results of haematological investigations (Table 5) conducted on day 29, 
revealed no significant changes in the values of different parameters investigated when 
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compared with control group. However, the increase or decrease in the values obtained 
was within normal biological and laboratory limits or the effect was not dose 
dependent. The Lymphocyte count was slightly elevated in test groups, but statistically 
not significant when compared with control group. 
 Biochemical Investigations: 
 Results of Biochemical investigations conducted on day 29. No significant 
changes in the values of different parameters studied when compared with those of 
respective controls; however, the values obtained were within normal biological and 
laboratory limits. (Table 6,7,8 ) 
Histopathology:  
Gross pathological examination of animals doesn’t reveal any abnormalities in 
control and test groups. The histopathological study of the organs such as Heart, 
Lungs, Liver, Spleen, Stomach and Kidney was normal in control, Low dose group, 
Mid dose group and High dose group.  
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HISTOPATHOLOGICAL REPORT 
 
HEART 
Control Group 
Section of the heart shows normal appearing cardiac myocytes (Slide 1) 
 
Low Dose 
Section of the heart shows normal appearing cardiac myocytes. (Slide 2)  
 
Mid Dose 
Section of the heart shows normal appearing cardiac myocytes. (Slide 3)  
 
 High Dose 
Section of the heart shows normal appearing cardiac myocytes. (Slide 4) 
  
  
 
 
104 
 
HEART 
 
 
           
Slide1: Cardiac Myocytes   Slide 3: Cardiac Myocytes  
 
 
        
Slide 2: Cardiac Myocytes                  Slide 4: Cardiac Myocytes 
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KIDNEY 
Control Group 
Section of the kidney shows normal appearing glomeruli ,tubules and interstitium.          
(Slide 1)    
 
Low Dose 
Section of the kidney shows normal appearing glomeruli ,tubules and interstitium.            
(Slide 3)  
 
Mid Dose 
Section of the kidney shows normal appearing glomeruli ,tubules and interstitium.          
(Slide 3)  
 
High Dose 
Section of the kidney shows normal appearing glomeruli ,tubules and interstitium.             
(Slide 4)  
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KIDNEY 
 
  
                               
          slide1: Glomeruli Tubules                              Slide 2: Glomeruli Tubules 
 
 
 
                             
   
         Slide 3: tubules on interstitium    Slide 4: Glomeruli Tubules 
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LIVER 
 
 Control Group 
Section from the liver shows central vein surrounded by radiating cords of hepatocytes separated 
by sinusoid containing kupfer cells portal triads of appear normal. (Slide 1) 
 
Low Dose 
Section from the liver shows central vein surrounded by radiating cords of hepatocytes separated 
by sinusoid containing kupfer cells portal triads of appear normal. (Slide 2)  
 
Mid Dose 
Section from the liver shows central vein surrounded by radiating cords of hepatocytes separated 
by sinusoid containing kupfer cells portal triads of appear normal. (Slide 3) 
 
High Dose 
Section from the liver shows central vein surrounded by radiating cords of hepatocytes separated 
by sinusoid containing kupfer cells portal triads of appear normal. ( Slide 4) 
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LIVER 
 
 
                              
Slide 1: central vein with hepatocytes         Slide 2 : Portal Triad 
 
                           
  Slide 3: central vein with hepatocytes        Slide4: Portal Traid 
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LUNG 
 
Control Group 
Section from the lung shows normal appearing bronchioles, alveoli (Slide 1) 
 
Low Dose 
Section from the lung shows normal appearing bronchioles, alveoli. (Slide 2) 
 
Mid Dose 
Section from the lung shows normal appearing bronchioles, alveoli. ( Slide 3 ) 
 
High Dose 
 Section from the lung shows, bronchioles, alveoli were normal. (Slide 4) 
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LUNG 
 
                              
 Slide 1: Bronchioles And Alveoli         Slide 2: Bronchioles And Alveoli 
 
 
       
Slide 3: Bronchioles, Alveoli 
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STOMACH 
 
Control Group 
 
 Section from the stomach shows lined by stratified squamous epithelium gastric mucosa, 
muscularis mucosa, muscularis propria appear normal. (Slide 1) 
 
Low Dose 
 
 Section from the stomach shows lined by stratified squamous epithelium gastric mucosa, 
muscularis mucosa, muscularis propria appear normal. (Slide 2) 
 
Mid Dose 
  
 Section from the stomach shows lined by stratified squamous epithelium gastric mucosa, 
muscularis mucosa, muscularis propria appear normal. (Slide 3 ) 
 
High Dose 
  
 Section from the stomach shows lined by stratified squamous epithelium gastric mucosa, 
muscularis mucosa, muscularis propria appear normal. (Slide 4) 
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STOMACH 
 
 
 
Slide 1: normal gastric mucosa 
 
 
 
 
 
Slide 2 : Lamina Propria 
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SPLEEN 
 
Control Group 
 
 Section of the spleen shows normal white pulp with germinal centres.( Slide 1) 
 
Low Dose 
Section of the spleen shows white pulp with germinal center with arterioles surrounded and 
separated by congested red pulp. (Slide 2) 
 
Mid Dose 
Section of the heart shows white pulp with germinal center with arterioles surrounded and 
separated by congested red pulp. (Slide 3) 
 
High Dose 
Section of the heart shows white pulp with germinal center with arterioles surrounded and 
separated by congested red pulp. (Slide 4) 
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SPLEEN 
 
                          
Slide 1: central arterioles    Slide 2 : Red Pulb And White Pulb 
 
                          
Slide 3 : central arterioles    Slide4: central arterioles sorrunded  
by congested red pulp. 
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CHART 3 
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CHART 5 
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CHART 7 
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CHART 9 
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CHART 11 
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CHART 13 
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DISCUSSION 
 
Analysis of ‘Siddhar kulikai’  by various methods, provided the vital 
outcome. 
      In Physicochemical analysis of ‘Siddhar kulikai’  reveals, pH of  7.5 to 7.7 
Total Ash value of 8.77%, Moisture content of  9.75 %and Water soluble Ash 6.7% Acid 
insoluble ash 0.83%It indicates the ‘Siddhar kulikai’ is acidic in nature. The parameters 
showed the normal assortment. It reveals the purity of the medicine was fine eminence. 
       Analysis by HRSEM explicate the  Particle Size (Lump) of ‘Siddhar kulikai’ 
was  10μm. Agglomeration of the particles can be seen. Absorption of the drug was fine 
for the reason that the size of the fine particle was below the size of the lump. Absorption 
of the particles are possible.  
FTIR analysis indicates, after purification the raw drugs became more efficacious 
and safe nature is attained by introduction of few new groups and absence of toxic 
substituents.  
Analysis by ICP OES  explicate the ‘Siddhar kulikai’ were re-establish and add 
force  by the purification and preparation method. The level of Mercury was with in the 
permissible limit(0.86 ppm) this indicates the best eminence of the purification and 
preparation process. Other than Mercury, the level of Sulphur, Pottasium, Sodium, 
Calcium, Phosphorus were accomplish the therapeutic value. 
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 In Acute toxicity study, rats are treated with the dose level of 5mg/kg/bw, 
50mg/kg/bw, 300mg/kg/bw 2000mg/kg/bw.At 2000mg/kg bw dose level behavioral 
changes observed and no death were observed. And the animals were observed up to 14 
days. No death was recorded after 14 days. 
The doses selected for Repeated dose toxicity study were 3.024 mg(Low Dose), 
15.12 mg (Middle Dose), 30.24 mg (High Dose)and treated upto 28 days. All the male 
and female animals from control and all the treated dose groups up to 10x dose level 
survived throughout the dosing period of 28 days. Animals from all the treated dose 
groups exhibited comparable body weight gain with that of controls throughout the 
dosing period of 28 days.Food consumption of control and treated animals was found to 
be comparable throughout the dosing period of 28days.Haematological, biochemical 
analysis of collected blood samples from day 29 reveals, the survival of animals 
throughout  the dosing period in all the treated dose groups. No signs of major or 
significant intoxication were observed in animals during the dosing period of 28 days. 
Haematological analysis, Liver and Kidney function analysis revealed no remarkable 
abnormalities attributable to the treatment, Observation of the significant results does not 
reveals the toxic effect of the dose level because increase or decrease in the values 
obtained was within normal biological and laboratory limits. 
 Histopathological examination dose not reveal any abnormalities, in all treated 
dose group level when compared with control group, reveals the action of drug in every 
dose level dose not damage the organs. Histopathological analysis was necessary to 
elucidate the safety of the medicine.  
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SUMMARY  
 
Ø The medicine ‘Siddhar kulikai’  was taken for the dissertation work based 
on“Veerama munivar vagada thiratu, Part I.” 
Ø Pooram, Sithiramoola ver pattai , Omam, Panaivellam, Korosanai,  was bought 
from the raw drug shop, Chennai, Nagarkovil.  
Ø Ingrdients were  authenticated by Siddha Central Research Institute and 
Department of Botany,  NIS, Chennai. 
Ø Then the ingredients of ‘Siddhar kulikai’  was purified as per the literature in 
NIS Gunapadam lab. 
Ø And the medicine was prepared in NIS Gunapadam lab as per the literature. 
Ø The prepared medicine “Siddhar kulikai” was subjected to evaluate the Acute 
oral toxicity study and 28days repeated dose oral toxicity study in NIS 
pharmacology lab. 
Ø Qualitative analysis was done in NIS Biochemistry lab.  
Ø Subsequently the medicine was subjected to Physicochemical analysis, 
Quantitative analysis (ie)  HRSEM, ICP-OES,FTIR in  IIT Chennai.  
Ø Medicine was subjected for XRF analysis in SASTRA University,Thanjur. 
Ø the Qualitative analysis was done in NIS Biochemistry lab.  
Ø Histopathology  analysis were done in Madras Medical College, Pathology lab. 
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CONCLUSION 
Qualitative analysis and Quantitative analysis reveals the foremost purification and 
preparation of the medicine and bear out the therapeutic dose.Based on the toxicity study,  
no toxic effect was observed up to10x dose level (30.24mg/animal) of “ Siddhar 
kulikai” treated via oral route over a period of 28 days. So, it can be concluded that the 
Siddhar kulikai is safety with the dosage recommendations of 56 to 84 mg which is 
mentioned in “Veerama munivar vagada thiratu, Part I.”is a safe dosage for clinical 
use. 
In forthcoming days this study will be augment by do the Pharmacological 
activity, Antimicrobial activity, and Clinical trial of “ Siddhar kulikai”. 
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